TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Government

    Congressional Dish

    An independent podcast examining what the U.S. Congress is doing with our money and in our names.

    www.congressionaldish.com
    Follow @JenBriney on Twitter

    Advertise

    Copyright: © 2022 Jennifer Briney

    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    CD261: Inflation Reduction Act Oct 30, 2022
    Show notes

    The Inflation Reduction Act is a new law designed to hasten the United States' energy transition (and do nothing about inflation). In the last episode before the midterm election, learn about the energy path the Democratic Party has plotted for us and learn how this new law can possibly save you tens of thousands of dollars. Please Support Congressional Dish – Quick Links Contribute monthly or a lump sum via PayPal Support Congressional Dish via Patreon (donations per episode) Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: 5753 Hwy 85 North, Number 4576, Crestview, FL 32536. Please make checks payable to Congressional Dish Thank you for supporting truly independent media! View the show notes on our website at https://congressionaldish.com/cd261-inflation-reduction-act Jen Podcast Appearances EP 63 Honest Government Analyst Jennifer Briney talks Privilege, White House & Hotels. The Living Numbers Podcast with Tony Rambles. Disaster - Jennifer Briney. A Word with Tom Merritt. Background Sources Recommended Congressional Dish Episodes CD259: CHIPS: A State Subsidization of Industry CD250: Congress Saves the Postal Service CD246: BIF: Appalachian Chemical Storage CD240: BIF The Infrastructure BILL CD218: Minerals are the New Oil CD205: Nuclear Waste Storage CD146: Repeal & Replace CD048: The Affordable Care Act (Obamacare) Tax Credits and Refunds Home Energy Efficiency Tax Credits "Tax Credits for Energy Efficient Home Improvements." eFile. Rocky Mengle. Sept 16, 2022. "Save More on Green Home Improvements Under the Inflation Reduction Act." Kiplinger. "Federal Income Tax Credits and Other Incentives for Energy Efficiency." Updated Aug 18, 2022. Energy Star. Electric Appliance Rebates "Quick Facts: United States." U.S. Census Bureau. Electric Car Tax Credit 26 U.S. Code § 30D - Clean vehicle credit. Cornell Law School Legal Information Institute. Alternative Fuels Data Center. "Electric Vehicles with Final Assembly in North America." U.S. Department of Energy, Office of Energy Efficiency and Renewable Energy. Kelley R. Taylor. Oct 18, 2022. "EV Tax Credits Are Changing: What's Ahead." Kiplinger. Greg Iacurci. Oct 15, 2022. "The 'bummer' of the $7,500 electric vehicle tax credit: Its full value may be hard to get." CNBC. John Bozzella. Aug 5, 2022. "What If No EVs Qualify for the EV Tax Credit? It Could Happen." Alliance for Automotive Innovation. John Bogna. Jun 22, 2022. "Hydrogen-Powered Cars: Fuel Cell Electric Vehicles Explained." PCMag. U.S. Geological Survey. "Mineral Commodity Summaries 2021." U.S. Department of the Interior. "OFAC Sanctioned Countries." Princeton University Research & Project Administration. Alternative Fuel vehicle refueling property credit Kelley R. Taylor. Sept 14, 2022. "The Federal Tax Credit for Electric Vehicle Chargers is Back." Kiplinger. 26 U.S. Code § 30C - Alternative fuel vehicle refueling property credit. Cornell Law School Legal Information Institute. Hydrogen Catherine Clifford. Sep 8, 2022. "The clean hydrogen energy economy was a dream. The climate bill could make it a reality this decade." CNBC. Emma Ochu et al. Jun 17, 2021. "Hydrogen Fact Sheet: Production of Low-Carbon Hydrogen." Columbia University School of International and Public Affairs, Center on Global Energy Policy. "Lisa Murkowski." Open Secrets. Jay Bartlett and Alan Krupnick. December 2020. "Decarbonized Hydrogen in the US Power and Industrial Sectors: Identifying and Incentivizing Opportunities to Lower Emissions." Resources for the Future. 24/7 Wall St. Feb 16, 2020. "How Many Gas Stations Are In U.S.? How Many Will There Be In 10 Years?" Market Watch. Health Care "The Inflation Reduction Act Lowers Health Care Costs for Millions of Americans." Oct 5, 2022. Centers for Medicare & Medicaid Services. "Inflation Reduction Act: CMS Implementation Timeline." 2022. Centers for Medicare & Medicaid Services. Carbon Capture Angela C. Jones and Ashley J. Lawson. Oct 5, 2022. "Carbon Capture and Sequestration (CCS) in the United States." Congressional Research Service. Emily Pontecorvo. Aug 22, 2022. "Will the Inflation Reduction Act jumpstart carbon capture?" Grist. "Global Status of CCS 2021." 2021. Global CCS Institute. "Carbon capture and storage could also impact air pollution." Nov 17, 2011. European Environment Agency. Offshore Wind Leases Abby Husselbee and Hannah Oakes. Aug 25, 2022. "The IRA Offshore Energy Leasing Provisions' Potential Impacts." Harvard University Environmental & Energy Law Program. "Memorandum on the Withdrawal of Certain Areas of the United States Outer Continental Shelf from Leasing Disposition." Sept 8, 2020. The White House. Fossil Fuels David Jordan. Oct 6, 2022. "Interior moves forward with oil and gas drill site leasing." Roll Call. "Inflation Reduction Act Fossil Fuel Provisions." Aug 18, 2022. Enersection. 30 U.S. Code § 226 - Lease of oil and gas lands. Cornell Law School Legal Information Institute. The Associated Press. Apr 16, 2022. "Biden increases oil royalty rate and scales back lease sales on federal lands." NPR. Taxes Kelley R. Taylor. Oct 10, 2022. "The Inflation Reduction Act and Taxes: What You Should Know." Kiplinger. "Inflation Reduction Act includes 15% corporate minimum tax on book income." August 16, 2022. EY. Jacob Bogage. Aug 12, 2022. "The new Wall Street tax key to Democrats' Inflation Reduction Act." The Washington Post. Peter Warren. Aug 11, 2022. "'Inflation Reduction Act' Holds the SALT." Empire Center. "Lobbying: Intuit Inc." Open Secrets. "CBO Cost Estimate: H.R. 1 - the Tax Cuts and Jobs Act." November 13, 2017. Congressional Budget Office. The Law H.R.5376 - Inflation Reduction Act of 2022 "Summary: Estimated Budgetary Effects of H.R. 5376, the Inflation Reduction Act of 2022." Revised August 5, 2022. Congressional Budget Office. Audio Sources Full Committee Hearing On Opportunities and Challenges in Deploying Innovative Battery and Non-Battery Technologies for Energy Storage September 22, 2022 Senate Committee on Energy and Natural Resources Witnesses: Tim Hemstreet, Managing Director for Renewable Energy Development, PacifiCorp Spencer Nelson, Managing Director, Research and New Initiatives, ClearPath Ted Wiley, President and Chief Operating Officer, Form Energy 19:19 Sen. Joe Manchin (D-WV): When it comes to storage, there has rightly been a focus on the supply chain, particularly for lithium ion batteries that power electric vehicles and phones in our pockets and many other modern technologies. While we have benefited from the use of this important battery chemistry, the fact that China is responsible for 75% of global lithium ion battery production, including 60% of the world's cathode production and 80% of the world's anode production, should give everyone pause. That is why I was proud to champion Inflation Reduction Act which incentivized the onshoring of the entire battery supply chain, from the production and processing of raw materials, to the battery pack assembly and everything in between. Full Committee Hearing On Domestic Critical Mineral Supply Chains March 31, 2022 Senate Committee on Energy and Natural Resources Witnesses: Dr. Steve Fortier, Director, USGS National Minerals Information Center, U.S. Department of the Interior Scott Melbye, President, Uranium Producers of America Julie Padilla, Chief Regulatory Officer, Twin Metals Minnesota Abigail Wulf, Vice President, Critical Minerals Strategy and Director of the Center for Critical Minerals Strategy, Securing America's Future Energy Dr. Paul Ziemkiewicz, Director, West Virginia Water Research Institute, West Virginia University 24:14 Sen. Joe Manchin (D-WV): It makes no sense to remain beholden to bad actors when we have abundant resources in manufacturing know-how here in the United States. And make no mistake, we are beholden, particularly when it comes to many of the minerals that go into clean energy technologies. That is why I've sounded the alarm about going down the path of EVs alone and advocated for equal treatment for hydrogen 45:08 Abigail Wulf: As things stand, without some significant course corrections on America's critical minerals enterprise, the leading automobile power won't be the United States. It will be China. Not because of superior design or technology, but because of their massive head start and established market power, if not utter dominance, in all aspects of the supply chain that powers these [electric] vehicles. But simply mining alone does not begin to address the fundamentals of America's mineral supply chain challenge. Where we are most lacking and where China is most dominant is in that crucial but largely hidden processing phase and midstream component production. We simply can't dig up a rock and stick it in a Tesla. You have to crush it, smelt it, and refine it into precursor material that has been sold to somebody else to turn it into battery guts, namely cathodes, anodes and electrolytes. Today, the United States has less than 4% of all minerals processing capacity and makes 0% of the world's cathodes and anodes. By contrast, China is the world's largest processor of copper, nickel, cobalt, lithium and rare earth elements, and they control 60% of anode production and 40% of global cathode production. Consider that in 2019, about 70% of the world's cobalt supply was mined in the Democratic Republic of Congo, but more than 70% of that cobalt was refined in or controlled by China. Full Committee Hearing On Clean Hydrogen February 2, 2022 Senate Committee on Energy and Natural Resources Witnesses Dr. Sunita Satyapal, Director, Hydrogen and Fuel Cell Technologies Office, Hydrogen Program Coordinator, U.S. Department of Energy Dr. Glen Richard Murrell, Executive Director, Wyoming Energy Authority Jonathan Lewis, Senior Counsel and Director of Transportation Decarbonization, Clean Air Task Force Michael J. Graff, Chairman & Chief Executive Officer, American Air Liquide Holdings, Inc. Brian Hlavinka, Vice President, New Energy Ventures, Corporate Strategic Development, Williams 21:07 Sen. Joe Manchin (D-WV): However, we have some challenges to tackle in order to build a clean hydrogen economy. Producing hydrogen without emissions is two to six times the cost of current production methods. Also, retrofitting end-use applications to use hydrogen as a feedstock, from chemical plants to cars and trucks, will take huge investments from both public and private sectors. This is the demand that we need to develop hydrogen markets that can sustain themselves. The other big challenge is the safe and efficient transport and storage of large volumes of hydrogen, given its physical properties. There's a lot of promising work being done in this space and will allow us to leverage our vast natural gas pipeline network to transport hydrogen to market. 22:00 Sen. Joe Manchin (D-WV): That is why I made research, development, and demonstration of these technologies a central part of the Energy Infrastructure Act, which this committee reported with bipartisan support last year, and which was subsequently included in the recently enacted Bipartisan Infrastructure Law. In that bill, we fund $9.5 billion in research, development and demonstration of clean hydrogen, and we tasked the Department of Energy to develop a national strategy and a roadmap to get us to a clean hydrogen economy. 27:25 Sen. James Lankford (R-OK): I'm concerned that the conversation around green versus blue hydrogen will pit technologies against each other rather than working together to establish a robust hydrogen marketplace. The simple truth right now is that 95% of hydrogen produced in the United States is made from natural gas. 1:42:00 Sen. Lisa Murkowski (R-AK): Can you share what the administration's policy is with regards to converting natural gas to hydrogen? We recognize that there are some within the [Biden] administration, certainly some groups that may have influence on the administration, who are very firm about not using fuel sources like natural gas. So the question is, is there a role for conversion to play? And what might we anticipate with regards to support and funding that might come with it? Dr. Sunita Satyapal: Thank you again for the question. And as mentioned, with hydrogen shot, we're really looking at all of the pathways. It's really about clean hydrogen. So whether it's natural gas, carbon feedstocks, nuclear renewables, you know, any pathway to get to the low carbon intensity, we're really pivoting away from the colors. There's a lot of complexity: green, blue, purple, turquoise….Pyrolysis is another approach. In fact, our loan program office just announced financing of $1 billion solid carbon, which is another value added product, no need for the CCS portion. So definitely an all-of-the-above strategy needed to meet all of our goals. Full Committee Hearing to Examine Development and Deployment of Large-Scale Carbon Dioxide Management Technologies July 28, 2020 Senate Committee on Energy and Natural Resources Witnesses: Steven Winberg, (Former) Assistant Secretary for Fossil Energy at the US Department of Energy Shannon Angielski, Executive Director of the Carbon Utilization Research Council Dr. Julio Friedmann, Center on Global Energy Policy, Columbia University 25:06 Dr. Julio Friedmann: Net zero means that any residual emissions must be balanced by removal, as Secretary Moniz said. It means that reduction of co2 emissions and removal of co2 emissions are complementary but distinct actions and that both are necessary. The National Academies and the IPCC find that this must be done at enormous scale exceeding the size of the global oil and gas industry today. We are not where we need to be to make this real. 48:35 Shannon Angielski: In addition, the International Energy Agency modelled the contributions of different technologies to meet that mid-century 2 degree scenario. And it shows that CCUS accounts for approximately 100 Giga tons of needed global co2 emissions reductions by 2060. To put this into perspective, this would be achieved by the operation of 1100 carbon capture systems on the equivalent of 500 megawatt coal fired units, or 3200 natural gas combined cycle units, which would need to be operating for the next 30 years. 1:59:00 Steven Winberg: The rest of the world is going to continue using fossil energy, whether it's coal or oil or natural gas. And that's why we have moved forward quickly on the coal first program, because it offers the opportunity for what I think of as 21st century coal. Right now the Chinese own the space in power generation — coal fired power generation. We have an opportunity to take technology and springboard over what the Chinese are building, which is basically 1970s vintage technology that we built, and they now have improved slightly, but they're selling it around the world, to countries that have coal under their feet, and they're going to continue using that coal. But with the coal first program, we can move into power generation, and we can move into hydrogen production, because these countries also, as they build out their transport sector, may not do it the same way that developed countries, they may move more swiftly into hydrogen. And so there's an opportunity there to take our tec…

    Full show notes at the publisher

    CD260: Failure to Fund with Graham Elwood Oct 10, 2022
    Show notes

    Congress has failed to fund the government on time again. In this episode, Graham Elwood joins Jen as she geeks out on all the dingleberries attached to the new law extending Congress's funding deadline until December 16th. Episode Transcript Please Support Congressional Dish – Quick Links Contribute monthly or a lump sum via PayPal Support Congressional Dish via Patreon (donations per episode) Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: 5753 Hwy 85 North, Number 4576, Crestview, FL 32536. Please make checks payable to Congressional Dish Thank you for supporting truly independent media! View the shownotes on our website at https://congressionaldish.com/cd260-failure-to-fund-with-graham-elwood Graham Elwood Government Secrets Podcast with Lee Camp and Graham Elwood Political Vigilante Podcast Executive Producer Recommended Sources "From the Archive: Joe Hickman Blew the Whistle on Burn Pits 5 Years Ago." August 8, 2022. The Peter Collins Show. Background Sources Recommended Congressional Dish Episodes CD248: Understanding the Enemy CD244: Keeping Ukraine CD238: Losing Afghanistan CD176: Target Venezuela: Regime Change in Progress CD087: Run for Congress with Chris Clemmons FDA User Fees Katie Hobbins. Oct 3, 2022. "FDA User Fee CR Passed, Questions on Policy and Reform Riders Remain." Medical Device + Diagnostic Industry (MD+DI). New Mexico Fire Ryan Boetel. Sept 29, 2022. "$2.5 billion for fire damage relief included in spending bill." Albuquerque Journal. Associated Press. Jun 21, 2022. "US Forest Service admits 'multiple miscalculations' caused New Mexico fire." The Guardian. Elizabeth Miller and Jason Samenow. May 5, 2022. "Large fires are raging in New Mexico, and the worst may be coming." The Washington Post. Republicans and Disaster Relief Funding Sharon Zhang. Oct 3, 2022. "Every Single Florida House Republican Voted Against Disaster Relief Funding." Truthout. Zach Schonfeld. Oct 3, 2022. "Gaetz asks for Florida hurricane aid after voting against CR with FEMA funding." Lauren Book. Oct 3, 2022. "Today, President Biden included additional Florida counties as those considered major disaster areas…" [tweet] Sanjana Karanth. Oct 2, 2022. "Florida Senators Request More Federal Aid Despite Not Voting For Hurricane Relief." HuffPost. Anna Skinner. Sept 30, 2022. "Matt Gaetz Votes Against Disaster Relief Days After Hurricane Ian Hits." Newsweek. Sergio Bustos. Sept 30, 2022. "Marco Rubio, Rick Scott urge Senate leaders for more funds to recover, rebuild Florida after Hurricane Ian." Tallahassee Democrat. Patrick Leahy. Sept 9, 2022. "Hurricane Ian shows reason for FEMA Disaster Relief Fund." Vermont Biz. Jackson Water Crisis Anthony Warren. Sept 30, 2022. "$20 million federal allocation for Jackson water clears House of Representatives." Jackson WLBT. Michael Goldberg. Sept 27, 2022. "Funds to aid Jackson's water system held up as governor rose." Yahoo News. Annie Snider and Lara Priluck. Sept 21, 2022. "House appropriators eye as much as $200M for Jackson water crisis." Politico. James Brasuell. Aug 20, 2022. "Water Supply Failure in Jackson, Mississippi." Planetizen. Continuing Resolution Aidan Quigley. Sept 30, 2022. "Stopgap funding bill clears House; next stop is Biden's desk." Roll Call. David Hawkings. Sept 7, 2016. "What Is a Continuing Resolution?" Roll Call. Ukraine James Bradley. Oct 4, 2022. "Why does a hurricane relief bill have money for Ukraine in it? Seriously." [tweet] Emily Cochrane. Sept 29, 2022. "Senate Passes Bill to Aid Ukraine and Avert Government Shutdown." The New York Times. Chelsey Cox. Sept 29, 2022. "Senate passes stopgap funding bill to avert government shutdown, provide more Ukraine aid." CNBC. Jackie Walorski Crash Marek Mazurek. Sept 16, 2022. "Crash that killed U.S. Rep. Jackie Walorski, 3 others due in part to 'excessive speed.'" Appropriations "Appropriations Status Table: FY2023." Congressional Research Service. Jeff Sachs Jeff Sachs on Bloomberg Global Financial News LIVE. Oct 3, 2022. "This is a path of dangerous escalation." Bono. Apr 18, 2005. "The 2005 TIME 100: Jeffrey Sachs." TIME. Peter Passell. Jun 27, 1993. "Dr. Jeffrey Sachs, Shock Therapist." The New York Times. Campaign Contributions from the Defense Industry "Defense: Top Recipients: 2020" Open Secrets. Afghanistan Craig Whitlock. The Afghanistan Papers: A Secret History of the War. Simon & Schuster: 2021. Spencer Ackerman. Apr 29, 2013. "How the CIA's Bags of Cash Undermined the Afghanistan War." U.S. Infrastructure and Global Rankings "United Nations Sustainable Development Report Rankings." "The Global Competitiveness Report, 2019." Contaminated Water in the United States Gloria Oladipo. Sep 6, 2022. "Toxic arsenic levels make tap water unsafe for thousands in New York City." The Guardian. Emily Holden et. al. Feb 26, 2021. "More Than 25 Million Americans Drink From the Worst Water Systems." The Guardian. Maura Allaire. Feb 12, 2018. "National trends in drinking water quality violations." The Proceedings of the National Academy of Sciences (PNAS) 115(9). Paul Pelosi Chip Stock Caroline Vakil. Jul 27, 2022. "Pelosi's husband sells off up to $5 million worth of chipmaker stock ahead of semiconductor bill vote." The Hill. Starbucks Unionization "Current Starbucks Statistics." Union Election Data. Laws and Treaties H.R.6833: Making continuing appropriations for fiscal year 2023, and for other purposes Congressional Budget Office Cost Estimate Protocols to the North Atlantic Treaty of 1949 on the accession of Poland, Hungary, and the Czech Republic Vote breakdown Audio Sources Jeff Sachs on Bloomberg Global Financial News LIVE Oct 3, 2022 Jeff Sachs: The main fact is that the European economy is getting hammered by this by the sudden cut off of energy. And now to make it definitive the destruction of the Nord Stream pipeline, which I would bet was a US action, perhaps the US and Poland. This is a speculation — Bloomberg Host: That's quite a statement. Why do you feel that that was a US action? What evidence do you have of that? Jeff Sachs: Well, first of all, there's direct radar evidence that US helicopters, military helicopters that are normally based in Gdansk, we're circling over this area. We also had the threats from the United States earlier in this year that one way or another, we are going to end Nord Stream. We also have a remarkable statement by Secretary Blinken, last Friday in a press conference, he says this is also a tremendous opportunity. It's a strange way to talk if you're worried about piracy on international infrastructure of vital significance. I know this runs counter to our narrative, that you're not allowed to say these things in the West, but the fact of the matter is, all over the world, when I talk to people, they think the US did it. And by the way, even reporters on our papers that are involved tell me privately, "Well, of course," but it doesn't show up in our media. House Session September 30, 2022 Jen's Highlighted PDF Senate Session September 29, 2022 Jen's Highlighted PDF Senate Session April 30, 1998 Jen's Highlighted PDF Cover Art Design by Only Child Imaginations Music Presented in This Episode Tired of Being Lied To by David Ippolito


    CD259: CHIPS: A State Subsidization of Industry Sep 23, 2022
    Show notes

    A new law, known as the CHIPS Act, provides over $50 billion to existing, profitable companies to fund new semiconductor production facilities in the United States. In this episode, we examine why Congress decided to gift these companies our tax money now and explore the geopolitical implications of this funding decision. Beyond semiconductors, the law provides further corporate welfare for the creation of things that many of us tax payers likely support. This law is complicated; let's get nuanced. Episode Transcript Please Support Congressional Dish – Quick Links Contribute monthly or a lump sum via PayPal Support Congressional Dish via Patreon (donations per episode) Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: 5753 Hwy 85 North, Number 4576, Crestview, FL 32536. Please make checks payable to Congressional Dish Thank you for supporting truly independent media! View the show notes on our website at https://www.congressionaldish.com/cd259-chips-a-state-subsidization-of-industry Background Sources Recommended Congressional Dish Episodes CD230: Pacific Deterrence Initiative CD218: Minerals are the New Oil CD215: COVID-19 Testimony CD205: Nuclear Waste Storage CD187: Combating China CD186: National Endowment for Democracy CD128: Crisis in Puerto Rico Semiconductor Industry "Pass the CHIPS Act of 2022 Fact Sheet." July 2022. Semiconductor Industry Association. "Global Semiconductor Incentives." February 2022. Semiconductor Industry Association. "2021 State of the U.S. Semiconductor Industry." September 2021. Semiconductor Industry Association. Taiwan Bansari Mayur Kamdar and Medha Singh. Aug 2, 2022. "Chip stocks slip as Taiwan tensions mount." Reuters. Karen M. Sutter. Mar 7, 2022. "U.S.-Taiwan Trade Relations" [IF10256]. Congressional Research Service. Yimou Lee, Norihiko Shirouzu and David Lague. Dec 27, 2021. "T-DAY: The Battle for Taiwan." Reuters. PRISM Program Derek B. Johnson. Aug 27, 2018. "Court case puts PRISM back in the spotlight." FCW. Wealthy Shareholders Juliana Kaplan and Andy Kiersz. Oct 19, 2021. "The wealthiest Americans now own almost all of the stock market — 89% to be exact." Insider. National Endowment for Democracy "Board of Directors." National Endowment for Democracy. National Science Foundation Directorate Mitch Ambrose. Mar 17, 2022. "NSF Stands Up Directorate for Technology, Innovation, and Partnerships." American Institute of Physics. "Chairwoman Johnson and Ranking Member Lucas Welcome NSF Director Panchanathan's Announcement of New Directorate Aligned with Bipartisan Committee Proposal." Mar 17, 2022. House Committee on Science, Space, and Technology. Fusion Research "Nuclear Fission and Fusion." Diffen. "Client Profile: Commonwealth Fusion Systems: Summary." Open Secrets. "Client Profile: Commonwealth Fusion Systems: Lobbyists." Open Secrets. "Barton Gordon: Partner. K&L Gates. American Exception Book Aaron Good. 2022. American Exception: Empire and the Deep State. Skyhorse Publishing. The Law H.R. 4346: CHIPS Act of 2022 / Research and Development, Competition, and Innovation Act / Supreme Court Security Funding Act of 2022 GovTrack Overview Congressional Budget Office: Estimated Budgetary Effects of H.R. 4346 Bills Later Added to the CHIPS Act S. 3740: Micro Act of 2022 The one hearing H.R. 4863: Partnerships for Energy Security and Innovation Act S. 1359: Partnerships for Energy Security and Innovation Act of 2021 Audio Sources President Biden on Taiwan Sept 18, 2022 60 Minutes Scott Pelley: What should Chinese President Xi know about your commitment to Taiwan? President Joe Biden: We agree with what we signed on to a long time ago, that there's a One China policy and Taiwan makes their own judgments about their independence. We are not moving, we're not encouraging their being independent. That's their decision. Scott Pelley: But would US forces defend the island? President Joe Biden: Yes, if in fact, there was an unprecedented attack. Scott Pelley: [overdub] After our interview, a White House official told us US policy has not changed. Officially, the US will not say whether American forces would defend Taiwan. But the Commander in Chief had a view of his own. [interview] So unlike Ukraine, to be clear, sir, US forces, US men and women would defend Taiwan in the event of a Chinese invasion? President Joe Biden: Yes. Senator Bernie Sanders' Senate Session Speech Jul 27, 2022 Jen's Highlighted PDF The Future of U.S. Policy on Taiwan Dec 8, 2021 Senate Committee on Foreign Affairs 30:45 Sen. James Risch (R-ID): A unilateral change in the status quo regarding Taiwan would not only threaten the security and liberty of 23 million Taiwanese, but also significantly damage vital US interests and alliances in the Indo Pacific. We would lose a model of democracy at a time of creeping authoritarianism. It would give China a platform in the first island chain to dominate the Western Pacific and threaten, indeed, US homeland. The consequences for Japan security, and therefore, the US-Japan alliance, are hard to overstate. Semiconductor supply chains would fall into China's hands, and it would emboldened China in other territorial disputes, including with India, and in the South China Sea. Fostering a New Era of Fusion Energy Research and Technology Development November 17, 2021 House Committee on Science, Space, and Technology, Subcommittee on Energy Witnesses: Dr. Troy Carter, Director, Plasma Science and Technology Institute, University of California, Los Angeles and Chair, Fusion Energy Sciences Advisory Committee Long Range Planning Subcommittee Dr. Tammy Ma, Program Element Leader for High Energy Density Science, Lawrence Livermore National Laboratory Dr. Robert Mumgaard, CEO, Commonwealth Fusion Systems Dr. Kathryn McCarthy, Director, U.S. ITER Project Office Dr. Steven Cowley, Director, Princeton Plasma Physics Laboratory Clips Robert Mumgaard: However, from where I sit, I see three reasons why I'm very optimistic the US can create a definitive lead in this new industry. First, the growth of the private sector. Over $2.4 billion in private capital has been invested in the fusion companies that now number nearly 30. This is a similar amount of capital as in all the nuclear fission small modular reactor companies. This is coming from a large range of investors across venture capitalists, to university endowments, to large energy companies. And they're putting capital at risk in fusion because they understand that the world needs a fundamentally new source of clean energy if we are going to meet our decarbonization goals. And these companies are highly ambitious, with a recent survey stating that 84% of them believe that fusion will be on the grid in the 2030s or earlier. Robert Mumgaard: We will proceed with the commercialization of our first fusion pilot plant called ARC. We hope to have that online in the early 2030s. Robert Mumgaard: The second reason I'm optimistic is that the public program has produced a consensus plan. Detailed in the National Academies and FESAC (Fusion Energy Sciences Advisory Committee) Recommendations is a transition of the public funded program towards the US developing commercial energy. We need to stop some activities and transition to others. But the researchers are enthusiastic and they are ready. We have a new generation of leaders at national laboratories and universities hungry to develop that technology. And that plan has been authorized but has not yet been implemented. Robert Mumgaard: And we're not alone. The other companies like TAE and General Fusion, Helion, Tokamak Energy, are looking at similar timeframes and experiencing similar growth. All these companies are looking to see which governments are going to be the best partners. And unfortunately, we are already seeing defections, with a major facility that could have been built in the US, instead being built in the UK. It'd be much better if the US public program leveraged the private sector, aligning with the technical goals and timelines to keep it happening here. Robert Mumgaard: The third reason I'm hopeful is the movement towards public private partnerships and we know that when the public and private sectors work together and recognize what each side is good at, we create vibrant ecosystems. We saw this in commercial space, with NASA and SpaceX. We saw it even more recently with the COVID-19 vaccine Supply Chain Integrity October 1, 2020 Senate Committee on Armed Services, Subcommittee on Readiness and Management Support Watch on CSPAN Witness: Ellen M. Lord, Under Secretary of Defense for Acquisition and Sustainment 1:22:10 Ellen Lord: I believe there may well be a lot of this, frankly: not continuing to engage with these Chinese companies on sensitive issues, but in turn, developing industrial bases here that makes us not reliant on that back and forth. There's quite a bit of discussion within the inner agency right now about constraining Chinese involvement from everything from investments to specific commodities. But again, I think one of the areas where we could have the most impact on China broadly, is reshoring microelectronics. And right now, my team is working very closely across DOD, as well as the inner agency to come up with a very specific recommendation for some public-private partnerships in order to develop the capability here domestically. We at DOD are only about 1% of the overall microelectronics market, however, we have some critical needs. Attorney General Barr's Remarks on China Policy at the Gerald R. Ford Presidential Museum July 16, 2020 15:20 Attorney General Bill Barr: "Made in China 2025" is the latest iteration of the PRC's state-led, mercantilist economic model. For American companies in the global marketplace, free and fair competition with China has long been a fantasy. To tilt the playing field to its advantage, China's communist government has perfected a wide array of predatory and often unlawful tactics: currency manipulation, tariffs, quotas, state-led strategic investment and acquisitions, theft and forced transfer of intellectual property, state subsidies, dumping, cyberattacks, and industrial espionage. Cover Art Design by Only Child Imaginations Music Presented in This Episode Tired of Being Lied To by David Ippolito


    CD258: Gain of Function Research Sep 18, 2022
    Show notes

    On August 3rd, Senate Republicans held a hearing examining gain of function research: its possible role in creating the COVID-19 pandemic; the problems with oversight of this dangerous research; and recommendations to Congress for how to fix those problems. Episode Transcript Please Support Congressional Dish – Quick Links Contribute monthly or a lump sum via PayPal Support Congressional Dish via Patreon (donations per episode) Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: 5753 Hwy 85 North, Number 4576, Crestview, FL 32536. Please make checks payable to Congressional Dish Thank you for supporting truly independent media! Watch Jen's Interview on CSPAN!!! Background Sources Gain-of-function Research Talha Burki. Feb 1, 2018. "Ban on gain-of-function studies ends." The Lancet Infectious Diseases 18(2): pp 148-149. "Framework for Guiding Funding Decisions about Proposed Research Involving Enhanced Potential Pandemic Pathogens." 2017. U.S. Department of Health and Human Services. Michael J. Selgelid. Aug 8, 2016. "Gain-of-Function Research: Ethical Analysis." Science and Engineering Ethics 22(4): pp 923-964. Sara Reardon. October 22, 2014. "US suspends risky disease research." Nature 514: pp 411-412. "Doing Diligence to Assess the Risks and Benefits of Life Sciences Gain-of-Function Research." Oct 17, 2014. The White House Blog. Board on Life Sciences; Division on Earth and Life Studies; Committee on Science, Technology, and Law; Policy and Global Affairs; Board on Health Sciences Policy; National Research Council; Institute of Medicine. April 13, 2015. "Potential Risks and Benefits of Gain-of-Function Research: Summary of a Workshop." National Academies Press. Marc Lipsitch. Jun 29, 2014. "Anthrax? That's Not the Real Worry." The New York Times. COVID-19 Origin Theories Gary Ruskin. Sep 14, 2022. "Key articles on origins of Covid-19, gain-of-function research and biolabs." U.S. Right to Know. Alina Chan. Jul 30, 2022. "The evidence for a natural vs lab origin of Covid-19." Medium. Maria Cheng and Janey Keaten. Jun 9, 2022. "WHO: COVID origins unclear but lab leak theory needs study." AP News. "WHO Scientific Advisory Group for the Origins of Novel Pathogens (SAGO): preliminary report." Jun 9, 2022. World Health Organization. Carl Zimmer and James Gorman. Updated Oct 13, 2021. "A Group of Scientists Presses a Case Against the Lab Leak Theory of Covid." The New York Times. Richard Muller and Steven Quay. Oct 5, 2021. "Science Closes In on Covid's Origins." The Wall Street Journal. Steven Quay and Richard Muller. Jun 6, 2021. "The Science Suggests a Wuhan Lab Leak." The Wall Street Journal. "TWiV 762: SARS-CoV-2 origins with Robert Garry." May 30, 2021. This Week in Virology [Podcast]. Glenn Kessler. May 25, 2021. "Timeline: How the Wuhan lab-leak theory suddenly became credible." The Washington Post. Jorge Casesmeiro Roger. Mar 24, 2021. "An Interview with Richard Ebright: The WHO Investigation Members Were 'participants in disinformation.'" Independent Science News. Josh Rogin. Mar 8, 2021. "In 2018, Diplomats Warned of Risky Coronavirus Experiments in a Wuhan Lab. No One Listened." Politico. Jane Qiu. Jun 1, 2020. "How China's 'Bat Woman' Hunted Down Viruses from SARS to the New Coronavirus." Scientific American. EcoHealth Alliance and Funding for Coronavirus Research Katherine Eban. March 31, 2022. "'This Shouldn't Happen': Inside the Virus-Hunting Nonprofit at the Center of the Lab-Leak Controversy." Vanity Fair. Sharon Lerner and Maia Hibbett. Sep, 23 2021. "Leaked Grant Proposal Details High-Risk Coronavirus Research." The Intercept. Glenn Kessler. May 18, 2021. "Fact-checking the Paul-Fauci flap over Wuhan lab funding." The Washington Post. Meredith Wadman and Jon Cohen. Apr 30, 2020. "NIH's axing of bat coronavirus grant a 'horrible precedent' and might break rules, critics say." Science. National Institutes of Health. May 27, 2014. NIH grant to EcoHealth Alliance for Wuhan research. NIH RePORTER. NIH Database Data Removal Amy Dockser Marcus. Jun 23, 2021. "Chinese Covid-19 Gene Data That Could Have Aided Pandemic Research Removed From NIH Database." The Hearing Revisiting Gain of Function Research: What the Pandemic Taught Us and Where Do We Go From Here August 3, 2022 Senate Committee on Homeland Security and Governmental Affairs: Subcommittee on Emerging Threats and Spending Oversight Witnesses: Richard H. Ebright, Professor of Chemistry and Chemical Biology and Laboratory Director, Rutgers University Waksman Institute of Microbiology Testimony Steven Quay, CEO and Founder, Atossa Therapeutics, Inc. Testimony Kevin M. Esvelt, Associate Professor of Media Arts and Sciences, Massachusetts Institute of Technology Testimony Cover Art Design by Only Child Imaginations Music Presented in This Episode Tired of Being Lied To by David Ippolito


    CD257: PACT Act - Health Care for Poisoned Veterans Aug 21, 2022
    Show notes

    After decades of our government denying healthcare to veterans they exposed to poisonous toxins, the PACT Act - which will eventually provide this hard-fought-for care - is now law. In this episode, learn exactly who qualifies for these new benefits and when, discover the shocking but little-known events that led to their poisonings, and find out what exactly happened during those 6 days when Senate Republicans delayed the passage of the PACT Act. Please Support Congressional Dish – Quick Links Contribute monthly or a lump sum via PayPal Support Congressional Dish via Patreon (donations per episode) Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: 5753 Hwy 85 North, Number 4576, Crestview, FL 32536. Please make checks payable to Congressional Dish Thank you for supporting truly independent media! View the shownotes on our website at https://congressionaldish.com/cd257-pact-act-health-care-for-poisoned-veterans Background Sources Recommended Congressional Dish Episodes CD249: A Few Good Laws CD205: Nuclear Waste Storage CD195: Yemen CD161: Veterans Choice Program CD124: The Costs of For-Profit War CD107: New Laws & Veterans' Health Care What the PACT Does and Doesn't Do "BREAKING NEWS! Huge Step Forward for Veterans: PACT Act 2022 Adds New Presumptive Conditions for Burn Pit, Agent Orange, and Radiation Exposure." Aug 10, 2022. VA Claims Insider. Abraham Mahshie. Aug 10, 2022. "Biden Signs PACT Act to Expand VA Coverage for Toxic Exposure, but Some Are Left Out." Air Force Magazine. Leo Shane III. Aug 4, 2022. "Now that PACT Act has passed, how soon will veterans see their benefits?" Military Times. "The PACT Act and your VA benefits." U.S. Department of Veterans Affairs. The VA Sidath Viranga Panangal, Jared S. Sussma, and Heather M. Salaza. Jun 28, 2022. "Department of Veterans Affairs FY2022 Appropriations" [R46964]. Congressional Research Service. "VA health care." U.S. Department of Veterans Affairs. "Eligibility for VA health care." U.S. Department of Veterans Affairs. "Your health care costs." U.S. Department of Veterans Affairs. Toxic Exposures Burn Pits "Ten things veterans should know about burn pits." November 20th, 2014. VAntage Point. "DoD concedes rise in burn-pit ailments." Feb 8, 2010. Military Times. "Operation Desert Shield." U.S. Army Center of Military History. "Operation Desert Storm." U.S. Army Center of Military History. Agent Orange Donnie La Curan. April 1, 2021. "Agent Orange Laos Victims Never Acknowledged by U.S." Veterans Resources. Charles Dunst. Jul 20, 2019. "The U.S.'s Toxic Agent Orange Legacy." The Atlantic. Patricia Kime. May 11, 2020. "Report Claims Vietnam-Era Veterans Were Exposed to Agent Orange on Guam." Military.com. "Clinic Issues Report Confirming Guam Veterans' Exposure to Dioxin Herbicides Like Agent Orange." May 11, 2020. Yale Law School. "Agent Orange - Johnston Island Atoll, AFB." Vietnam Security Police Association. Susan E. Davis. Apr 9, 1991. "The Battle Over Johnston Atoll." The Washington Post. Enewetak Atoll Chris Shearer. Dec 28, 2020. "Remembering America's Forgotten Nuclear Cleanup Mission." Vice. "The Radiological Cleanup of Enewetak Atoll. March 2018. U.S. Defense Threat Reduction Agency. Dave Philipps. Jan 28, 2017. "Troops Who Cleaned Up Radioactive Islands Can't Get Medical Care." The New York Times. Palomares, Spain Nuclear Accident "New Federal Suit Filed Against VA on Behalf of Veterans Exposed to Radiation at Palomares Nuclear Cleanup." November 1, 2021. Yale Law School Today. Dave Philipps. June 19, 2016. "Decades Later, Sickness Among Airmen After a Hydrogen Bomb Accident." The New York Times. "Palomares Nuclear Weapons Accident: Revised Dose Evaluation Report." April 2001. United States Air Force. U.S. Department of Energy. February 1966 "U.S. Position on Minimizing Soil Removal." U.S. Department of Energy Archives. Thule, Greenland Nuclear Accident Robert Mitchell. Jan 21, 2018. "Cataclysmic cargo: The hunt for four missing nuclear bombs after a B-52 crash." The Washington Post. MAAS v. U.S. 897 F.Supp. 1098 (1995). United States District Court, N.D. Illinois, Eastern Division. "Project Crested Ice: The Thule Nuclear Accident Volume 1 [SAC Historical Study 113]." June 1982. History and Research Division, Headquarters, Strategic Air Command. Captain Robert E. McElwee. "Project Crested Ice: USAF B-52 Accident at Thule, Greenland, 21 January 1968." U.S. Defense Technical Information Center. South Carolina Nuclear "Storage" Doug Pardue. May 21, 2017 (Updated Jun 28, 2021). "Deadly legacy: Savannah River site near Aiken one of the most contaminated places on Earth." The Post & Courier. Gulf War Illness "What is Gulf War Syndrome?" Johns Hopkins Medicine. "UTSW genetic study confirms sarin nerve gas as cause of Gulf War illness." May 11, 2022. UT Southwestern Medical Center Newsroom. Camp Lejeune Water Contamination "Camp Lejeune Water Contamination Claims | Veteran Owned Law Firm." The Carlson Law Firm on YouTube. "Camp Lejeune, North Carolina." Agency for Toxic Substances and Disease Registry. "Summary of the water contamination situation at Camp Lejeune." Agency for Toxic Substances and Disease Registry. "Health effects linked with trichloroethylene (TCE), tetrachloroethylene (PCE), benzene, and vinyl chloride exposure." Agency for Toxic Substances and Disease Registry. "Camp Lejeune Water Contamination History." Oct 18, 2009. St. Lawrence County Government. St. Louis Area Nuclear Contamination Chris Hayes. Jul 27, 2022. "Flooding around nuclear waste renews residents' fears." Fox 2 Now - St. Louis. Jim Salter. Mar 19, 2022. "West Lake Landfill cleanup slowed after more nuclear waste found." St. Louis Post-Dispatch. Jesse Bogan. Dec 20, 2021. "Concerns linger as completion date for Coldwater Creek cleanup pushed to 2038." St. Louis Post-Dispatch. "Evaluation of Community Exposures Related to Coldwater Creek." Apr 30, 2019. U.S. Agency for Toxic Substances and Disease Registry. Robert Alvarez. February 11, 2016. "West Lake story: An underground fire, radioactive waste, and governmental failure." Bulletin of the Atomic Scientists. "Westlake Landfill, Bridgeton, MO." U.S. Environmental Protection Agency. "Atomic Homefront." HBO Documentaries. Hanford Waste Management Site "Hanford's Dirty Secret– and it's not 56 million gallons of nuclear waste." Jul 26, 2019. The International Campaign to Abolish Nuclear Weapons. Biden Drone Bombing "'Cutting-edge technology used to eliminate Zawahiri.'" Aug 7, 2022. The Express Tribune. Jon Stewart People Staff. August 11, 2022. "Jon Stewart Shares His Emotional Reaction to Signing of Veterans Health Bill: 'I'm a Mess'" People. Republican F*ckery Ryan Cooper. Aug 3, 2022. "Republicans Just Exposed Their Greatest Weakness." The American Prospect. Jordain Carney and Anthony Adragna. August 1, 2022. "Senate GOP backtracks after veterans bill firestorm." Politico. "Roll Call 455 | H. J. Res. 114: To Authorize the Use of United States Armed Forces Against Iraq." Oct 10, 2022. Clerk of the U.S. House of Representatives. U.S. Foreign Wars No One Talks About Ellen Knickmeyer. Jun, 16 2022. "GAO: US Failed to Track if Arms Used Against Yemen Civilians." Military.com. Joseph R. Biden. June 08, 2022. "Letter to the Speaker of the House and President pro tempore of the Senate regarding the War Powers Report." The White House. Muhammad Fraser-Rahim. Oct 16, 2017. "The Deaths of Four Elite U.S. Soldiers in Niger Show Why Trump Must Wake Up on Terrorism in Africa." Newsweek. Overseas Contingency Operations Emily M. Morgenstern. Updated August 13, 2021. "Foreign Affairs Overseas Contingency Operations (OCO) Funding: Background and Current Status" [IF10143 ]. Congressional Research Service. Todd Harrison. Jan 11, 2017. "The Enduring Dilemma of Overseas Contingency Operations Funding." Center for Strategic and International Studies The Law S. 3373: Honoring our PACT Act Jen's Highlighted PDF of S. 3373 - Final Version Timeline of Votes and Changes June 16, 2022 Senate Roll Call Vote July 12, 2022. "Comparative Print: Bill to Bill Differences Comparing the base document BILLS-117hr3967eas.xml with BILLS-117S3373ES-RCP117-56." U.S. House of Representatives. July 13, 2022 House Roll Call Vote July 27, 2022 Senate Roll Call Vote August 1, 2022. "Amendments Submitted and Proposed." Congressional Record -- Senate. Audio Sources President Biden signs the PACT Act, expanding healthcare for veterans exposed to toxins August 10, 2022 PBS NewsHour on YouTube "Justice has been delivered": Biden says top al-Qaeda leader killed in drone strike August 1, 2022 Global News on YouTube "Camp Lejeune Water Contamination Claims | Veteran Owned Law Firm." The Carlson Law Firm on YouTube Senator Toomey on State of the Union with Jake Tapper July 31, 2022 CNN Clips 7:00 Sen. Pat Toomey (R-PA): Here's what you need to keep in mind, Jake. First of all, this is the oldest trick in Washington. People take a sympathetic group of Americans — it could be children with an illness, it could be victims of crime, it could be veterans who have been exposed to toxic chemicals — craft a bill to address their problems, and then sneak in something completely unrelated that they know could never pass on its own and dare Republicans to do anything about it because they know they'll unleash their allies in the media and maybe a pseudo-celebrity to make up false accusations to try to get us to just swallow what shouldn't be there. That's what's happening here, Jake. 10:40 Jake Tapper: So one of the questions that I think people have about what you're claiming is a budgetary gimmick is, the VA budgets will always remain subject to congressional oversight, they can't just spend this money any way they want. And from how I read this legislation, it says that this money has to be spent on health care for veterans who suffered exposure from toxic burned pits. Sen. Pat Toomey (R-PA): This is why they do this sort of thing, Jake, because it gets very deep in the weeds and very confusing for people very quickly. It's not really about veteran spending. It's about what category of government bookkeeping, they put the veterans spending in. My change, the honest people acknowledge it will have no effect on the amount of money or the circumstances under which the money for veterans is being spent. But what I want to do is treat it, for government accounting purposes, the way we've always treated it for government accounting purposes. Because if we change it to the way that the Democrats want, it creates room in future budgets for $400 billion of totally unrelated, extraneous spending on other matters. Senator Toomey on Face the Nation with John Dickerson July 31, 2022 CBS News Clips 4:10 John Dickerson: 123 Republicans in the House voted for this, 34 Senate Republicans voted for it. Same bill. This week, the bill didn't change but the Republican votes did. Why? Sen. Pat Toomey (R-PA): Now, the Republican votes didn't change on the substance of the bill. Republicans have said we want an amendment to change a provision that has nothing to do with veterans health care. The Republicans support this. The Democrats added a provision that has nothing to do with veterans health care, and it's designed to change government accounting rules so that they can have a $400 billion spending spree. 6:25 Sen. Pat Toomey (R-PA): Honest Democrats evaluating this will tell you: if my amendment passes, not a dime change in spending on veterans programs. What changes is how the government accounts for it. John Dickerson: I understand, but the accounting change, as you know, is a result — the reason they put it in that other bucket is that it doesn't subject it to the normal triage of budgeting. And the argument is that the values at stake here are more important than leaving it to the normal cut and thrust of budgeting. Jon's Response To Ted Cruz's PACT Act Excuses July 29, 2022 The Problem with Jon Stewart on Youtube Clips 00:20 Sen. Ted Cruz (R-TX): What the dispute is about is the Democrats played a budgetary trick, which is they took $400 billion in discretionary spending and they shifted it to a mandatory one. Jon Stewart: What Ted Cruz is describing is inaccurate, not true, bulls ** t. This is no trick. Everything in the government is either mandatory or discretionary spending depending on which bucket they feel like putting it in. The whole place is basically a f * ing shell game. And he's pretending that this is some new thing that the Democrats pulled out, stuck into the bill, and snuck it past one Ted Cruz. Now I'm not a big-city Harvard educated lawyer, but I can read. It's always been mandatory spending so that the government can't just cut off their funding at any point. No trick, no gimmick, [it's] been there the whole f**king time. 1:50 Sen. Ted Cruz (R-TX): What's the Republicans made clear is, if we leave that spending as discretionary — don't play the budgetary trick — the bill will pass with 80 or 90 votes. Jon Stewart: I don't know how many other ways to say this, but there was no budgetary trick and it was always mandatory. And when they voted in the Senate on June 16, they actually got 84 votes. And you know who voted for that? Ted f*cking Cruz and every other one of those Republicans that switched their votes. There was no reason for them to switch the votes. The bill that passed the Senate 84 to 14 on June 16 has not had one word added to it by Democrats, or spending fairies, or anybody else. It's the same f*cking bill. 'I Call Bullshit!' Jon on the PACT Act Being Blocked in the Senate July 28, 2022 The Problem with John Stewart on YouTube Clips 3:20 Jon Stewart: June 16, they passed the PACT Act 84 to 14. You don't even see those scores in the Senate anymore. They passed it. Every one of these individuals that has been fighting for years, standing on the shoulders of Vietnam veterans who have been fighting for years, standing on the shoulders of Persian Gulf War veterans fighting for years, Desert Storm veterans, to just get the health care and benefits that they earn from their service. And I don't care if they were fighting for our freedom. I don't care if they were fighting for the flag. I don't care if they were fighting because they wanted to get out of a drug treatment center, or it was jail or the army. I don't give a shit. They lived up to their oath. And yesterday, they spit on it in abject cruelty. These people thought they could finally breathe. You think their struggles end because the PACT Act passes? All it means is they don't have to decide between their cancer drugs and their house. Their struggle continues. From the crowd: This bill does a lot more than just give us health care. Jon Stewart: It gives them health care, gives them benefits, lets them live. From the crowd: Keeps veterans from going homeless keeps veterans from become an addict, keeps veterans from committing suicide. Jon Stewart: Senator Toomey is not going to hear that b…

    Full show notes at the publisher

    CD256: Poisonous Pet Collars Jul 30, 2022
    Show notes

    Seresto Flea and Tick Collars for dogs and cats have been sold to Americans since 2013. During that time, the EPA has received approximately 100,000 reports of illnesses and 2,500 reports of deaths of animals that wore a Seresto Flea and Tick collar, by far the most reports received about any flea and tick treatment on the market. In this episode, hear testimony from scientists about the Environmental Protection Agency's disturbingly lax review processes for pesticides in pet products and learn why your vote in November is likely to determine if these popular but dangerous products will stay on American shelves. Please Support Congressional Dish – Quick Links Contribute monthly or a lump sum via PayPal Support Congressional Dish via Patreon (donations per episode) Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: 5753 Hwy 85 North, Number 4576, Crestview, FL 32536. Please make checks payable to Congressional Dish Thank you for supporting truly independent media! Listen to the latest episode of Jen's new podcast with Andrew Heaton and Justin Robert Young — We're Not Wrong Episode 12: About The Never Ending Ukraine War, Biden's COVID and Mike Pence (LIVE FROM BERLIN) To report an incident directly to the EPA via email Report.Pesticide.Incident@epa.gov View the shownotes on our website at https://congressionaldish.com/cd256-poisonous-pet-collars Executive Producer Recommended Sources CD200: How to End Legal Bribes Bruce Bueno de Mesquita and Alastair Smith. The Dictator's Handbook: Why Bad Behavior is Almost Always Good Politics. Public Affairs: 2011. Background Sources Recommended Congressional Dish Episodes CD254: Baby Formula Shortage CD234: AWOL Recall: The Rock and Play Sleeper Reports on Seresto and Pesticides "Oversight Subcommittee Report Reveals EPA Failed to Protect Pets, Owners From Dangerous Flea and Tick Collar." Jun 15, 2022. House Committee on Oversight and Reform. House Committee on Oversight and Reform, Subcommittee on Economic and Consumer Policy. June 2022. "Staff Report: Seresto Flea and Tick Collars: Examining why a product linked to more than 2,500 pet deaths remains on the market." Lauretta Joseph. May 19, 2022. "Notification of Evaluation: The EPA's Response to Reported Incidents of Unintended Effects from Pet Collar Pesticides, Project No. OSRE-FY22-0120" Johnathan Hettinger. Sept. 24, 2021. "Is your pet wearing a Seresto flea collar? Company reports thousands more adverse incidents." USA Today. Jordan Liles. Mar 8, 2021. "Did Seresto Flea Collars Cause 1,698 Dog and Cat Deaths?" Snopes. Johnathan Hettinger. Mar 2, 2021. "Popular flea collar linked to almost 1,700 pet deaths. The EPA has issued no warning." USA Today. Jen's highlighted copy Lawrence J. Dyckman et al. July 1995. "Pesticides: EPA's Efforts to Collect and Take Action on Exposure Incident Data, GAO/RCED-95-163." U.S. Government Accountability Office. Lobbying "Lobbyist Profile: Ryan Canfield." 2022. Open Secrets. "Employment History: Ryan Canfield." Open Secrets. "Elanco Animal Health." Open Secrets. The Hearing Seresto Flea and Tick Collars: Examining why a product linked to more than 2,500 pet deaths remains on the market June 15, 2022 Committee on Oversight and Reform, Subcommittee on Economic and Consumer Policy Witnesses: Faye Hemsley & Omarion Hemsley, Owners of Deceased Pet Thomas Maiorino, Owner of Deceased Pet Jeffrey Simmons, President and Chief Executive Officer, Elanco Animal Health Incorporated Nathan Donley, Ph.D, Environmental Health Science Director, Center for Biological Diversity Karen McCormack, Former Scientist, Policy Analyst, and Communications Officer (ret.), Office of Pesticide Programs, Environmental Protection Agency Carrie Sheffield (minority witness), Senior Policy Analyst, Independent Women's Voice Clips 1:20 Rep. Raja Krishnamoorthi (D-IL): As early as 2015, just a few years after the collar entered the US market, an EPA investigation found that among similar products, the Seresto collar "ranked number one" by a wide margin in terms of total incidents, major incidents and deaths, even after factoring in companies' relative sales. Those findings weren't enough to drive the makers of Seresto collar or the EPA to act. 1:50 Rep. Raja Krishnamoorthi (D-IL): In 2016, Canada's equivalent of the EPA known as the PMRA, concluded based on a review of the same American data available to the EPA that the collar posed too great a risk to pets and their owners to be ever sold in Canada. 2:10 Rep. Raja Krishnamoorthi (D-IL): Even as the death count rose, the EPA allowed Seresto to remain on the market here without even so much as requiring additional warning labels that regulators mandated in places ranging from Australia to Colombia to the European Union. 2:30 Rep. Raja Krishnamoorthi (D-IL): The companies that manufactured the Seresto collar first Bayer animal health and then later Elanco were also aware of the risks, the incidents and the deaths, but they too failed to act. Instead, they hired third party industry insiders to conduct so-called independent reviews of the incident data, which ended up protecting their $300 million a year market but ended up endangering pets. So the Seresto collar stayed the same and so did the consequences. 4:15 Rep. Raja Krishnamoorthi (D-IL): This particular collar has caused 100,000 incidents reported to the EPA and over 2500 pet deaths reported to the EPA. 4:30 Rep. Raja Krishnamoorthi (D-IL): The steps that we are asking for today are crucial, because it's important to protect our pets and our families, too. I now call upon my distinguished colleague, Mr. Cloud for his opening statement. Rep. Michael Cloud (R-TX): Thank you, Chairman. This is the first hearing of the Economic and Consumer Policy Subcommittee this year, and we've been in session for 52 days this year. And our first hearing is on pet collars. And I do realize that our pets are a huge part of our lives, they enrich our families, they provide companionship for my kids, they've helped foster responsibility and compassion and care, important ethics we need in our society. Just recently, our family mourned the loss of our guinea pig, biscuit. And so pets are a huge part of our family lives. But I have to admit that when I saw that this was going to be on the agenda for this week, I cannot help but be concerned, especially coming from South Texas about the 1000s 10s of 1000s of human lives that have passed away due to fentanyl and due to an open border and due to the policies of this administration to continue to aid and abet cartels. And I realized that this is the economic and Consumer Policy Subcommittee. And so I think about economic policy happening right now and where the minds of the American people are. Gas is now averaging $5 A gallon nationwide. For the first time in history. We have not had a hearing. Inflation is at a 40 year high. We have not had a hearing, the American people cannot find baby formula. We still haven't had a hearing. I've mentioned fentanyl is killing Americans, especially our teens at unprecedented rates. We have not had a hearing. Biden's systemic elimination of the safe and secure border he inherited has led to the worst humanitarian and national security crisis in this country's history. We have not had a hearing this term, we could talk about how inflation is affecting the cost of owning a pet, including the increased cost of food, toys, accessories, but we're not talking about that either. Instead, we're holding a hearing on the pet collar, which fights fleas and ticks. And as any pet owner knows fleas and tick management is an essential part of pet care. But I'm not sure it's an essential part of congressional oversight, especially when we take in mind where the American people are at. And frankly, I've talked to a number of people in my district and others who live in other parts of the country and they are really surprised that this has risen to one of the top priorities of commerce at this time in juncture. The subcommittee Republicans would rather explore efforts to help American consumers during these trying times, we would gladly have joined the chairman in holding a hearing on the shortage of baby formula. Moreover, we have welcomed the chance to explore TikTok's troubling practice of showing dangerous content to minors, an investigation you all started last year. In fact, it's now come to light that teenagers are using tick tock and other social media platforms to purchase illicit drugs including unknowingly in many cases, in most cases, fentanyl. Social media platforms are also using it to recruit young people into the gig economy of human trafficking. A hearing on that crisis could be incredibly important. And on the subject of our nation's youth, CDC bureaucrats have actively pursued an agenda to close schools during the pandemic instead of following the science damaging our children's financial, mental, physical, emotional, and also their learning for years to come. But we still have not had a hearing. Americans are facing incredible economic issues which require us as elected officials to listen and to respond. I do appreciate the fact that our pets play an important part of our lives. We should be kind to animals and we should teach our children to do the same. But I do care immensely more about the human lives that we were elected to serve. 10:20 Rep. Raja Krishnamoorthi (D-IL): A recorded vote has been requested — we will pause while the we will get the clerk out. 12:00 Rep. Byron Donalds (R-FL): Mr. Chairman, it's already been about what? A minute and a half. Where's the clerk? Is the clerk on lunch and not here today? Rep. Krishnamoorthi (D-IL): I think the clerk is on the way Mr. Donalds, thank you. Rep. Donalds: Is the clerk sitting in the side office just hanging out? I mean, come on, Mr. Chairman. 21:20 Clerk: Mr. Cloud? Rep. Michael Cloud (R-TX): Yes Clerk: Mr. Cloud votes yes. Mr. Keller? Rep. Fred Keller (R-PA): Yes Clerk: Mr. Keller votes yes. Mr. Franklin? Rep. C. Scott Franklin (R-FL): Yes Clerk: Mr. Franklin votes yes. Mr. Clyde? Rep. Andrew Clyde (R-GA): Yes. Clerk: Mr. Clyde votes yes. Mr. Donalds? Rep. Byron Donalds (R-FL): Yes Clerk: Mr. Donalds votes yes. 26:31 Thomas Maiorino: My name is Thomas Maiorina. I reside in Mount Laurel, New Jersey with my wife Monica. I am the father of three boys. My youngest son, Robert turned 12 in 2011. After years of asking for a dog, he wore us down and we decided to rescue a dog from a southern shelter for my son's birthday. After researching online, we adopted a mixed breed mutt that Robbie and his two other brothers named Rooney. Rooney swiftly became a loved member of our family. A bit rambunctious, she was just what a 12 year old boy needed. She loved the run and chase anything the move in the yard. By all measures, we took great care to ensure Rooney had a healthy and happy life. We took her on daily walks, sometimes three a day, hikes on park trails. We monitor her diet and made sure she was seen by the veterinarian as needed, and she received all of her shots. Because she was a bit rambunctious and we lived in a wooded area where there's a lot of wildlife, we were constantly concerned about the problems of fleas and ticks. We consulted with a veterinarian after getting Rooney to determine the best way to protect her against this. We use a variety of prevention methods for the first few years and when we changed veterinarians in approximately 2013 or 14, the new veterinarian strongly recommended that we use the Seresto flea and tick collar, based on all of our options. We heeded that advice and purchased Seresto collars from our local PetSmart. The collars were intended to provide protection for up to eight months. We noticed that after fixing a collar to Rooney's neck, she began to itch and first had that treated and tested for allergies. We took her to the vet several times during 2018 seeking to find the cause for the ever increasing itching. After several visits and multielement medications, they were unable to determine the cause and we switched to a specialist in 2019 to seek further assistance, where they provided allergy shots and other medications to address the worsening itching and related symptoms. Rooney's behavior then became more erratic as the months wore on she began linking her paws so feverishly they would bleed. She also developed bleeding patches on her stomach. Ultimately, in October 2020, Rooney suffered horrendous grand mal seizure in the presence of myself and my wife. The damage done by the seizure was irreversible. She was a shell of her former self and ultimately, the family decided the most humane thing would be to put Rooney to sleep at the age of nine. In early March 2021, I read an article online about Seresto pet collars resulting in the deaths of 1700 Pets without any warnings from the EPA or the manufacturer. I sought out legal representation not because I wanted financial compensation, but because I took great pains to care for Rooney. The final 18 months of her life were agonizing to watch if I could help prevent another family from going through what my family went through. I wanted to act. I'm here today in furtherance of that effort. I appreciate the committee taking the time to investigate this matter. And thank you for your time. 33:30 Jeffrey Simmons: There are a few points I'd like to emphasize upfront. First, the EPA approved Seresto following more than 80 safety and toxicity studies, all of which show that Seresto and its ingredients have a strong safety profile. Second, more than 80 regulatory bodies around the world have approved Seresto. Seresto is widely used and more than 80 million collars worn over the past decade to protect dogs and cats from fleas and ticks around the world. 34:00 Jeffrey Simmons: Third, adverse event reports are not intended to be, and in fact are absolutely not, proof of causation. Reports require further investigation and analysis to determine cause. And after years of review, our pharmacovigilance team made up of veterinarians and other experts who study adverse event reports has not identified a single death caused by the active ingredients in the collar. 36:45 Jeffrey Simmons: No product is without risk. What matters is whether those risks are reasonable. And in light of the benefits and numerous studies and the incident report data for Seresto demonstrate the product does not pose an unreasonable risk and has a strong safety profile, which is why the American Veterinary Medical Association opposed canceling Seresto's EPA registration. 38:05 Nathan Donley: My name is Dr. Nathan Donley. I'm the science director for the Environmental Health Program at the Center for Biological Diversity. I have a PhD in Cell and Developmental Biology from Oregon Health and Sciences University. The last seven years of my professional life have been spent researching how pesticides impact people and the environment and the regulatory failures that can actually facilitate harm rather than prevent it. I published three peer reviewed scientific articles and five technical reports on this subject. I've authored over 100 technical scientific comments to the EPA on pesticide documents, including flumethrin and imidacloprid, the two active ingredients in the Seresto collar. I've read through 1000s of pages of FOIA documents I requested on matters related to the approval and continued use of Seresto. 39:40 Nathan Donley: While other a…

    Full show notes at the publisher

    CD255: Pharmacy Benefit Managers (PBMs) Jul 17, 2022
    Show notes

    The recently signed gun law, S. 2938: Bipartisan Safer Communities Act, contained a surprise dingleberry postponing a regulation designed to save seniors money on their pharmaceutical drugs by prohibiting kickbacks to an industry few have heard of: Pharmacy Benefit Managers (PBMs). This little-known but extremely powerful industry deserves much of the blame for ever rising prescription drugs costs in the United States. In this episode, Jen gives you the scoop on PBMs and how they make their money at the expense of Americans who are most dependent on medications. Please Support Congressional Dish – Quick Links Contribute monthly or a lump sum via PayPal Support Congressional Dish via Patreon (donations per episode) Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: 5753 Hwy 85 North, Number 4576, Crestview, FL 32536. Please make checks payable to Congressional Dish Thank you for supporting truly independent media! View the shownotes on our website at https://congressionaldish.com/cd255-pharmacy-benefit-managers-pbms We're Not Wrong Berlin Meetup Contact Justin at WereNotWrongPod@gmail.com Background Sources Recommended Congressional Dish Episodes CD134: The EpiPen Hearing US Healthcare Landscape Jessi Jezewska Stevens. Apr 23, 2020. "A Brief History of the Great American Healthcare Scam." Bookforum. Tanza Loudenback. Mar 7, 2019. "The average cost of healthcare in 21 different countries." Insider. Chuck Grassley and Ron Wyden. 2019. "Insulin: Examining the Factors Driving the Rising Cost of a Century Old Drug [Staff Report]." U.S. Senate Finance Committee. "Health Insurance Coverage of the Total Population." Kaiser Family Foundation. Sara R. Collins and David C. Radley. Dec 7, 2018. "The Cost of Employer Insurance Is a Growing Burden for Middle-Income Families." The Commonwealth Fund. PBMs What are PBMs? JC Scott. Jun 30, 2022. "Drug manufacturers are root cause of high drug costs; PBMs drive costs down." The Hill. Zach Freed. Jun 22, 2022. "The Pharmacy Benefit Mafia: The Secret Health Care Monopolies Jacking Up Drug Prices and Abusing Patients and Pharmacists." American Economic Liberties Project. Adam J. Fein. Jun 22, 2021. "The Top Pharmacy Benefit Managers of 2020: Vertical Integration Drives Consolidation (rerun)." Drug Channels. "Flash finding: How drug money from sick people really works." Nov 11, 2021. 46brooklyn. Adam J. Fein. Feb 3, 2019. "Don't Blame Drug Prices on 'Big Pharma.'" The Wall Street Journal. How PBMs Make Money "DIR Fees." National Association of Chain Drug Stores. "How PBMs Make Money: PBM Practices & Profits." RxSafe. True North Political Solutions. Oct 25, 2017. "White Paper: DIR Fees Simply Explained." Pharmacy Times. ACA "Vertical Integration" Loophole Peter High. Jul 8, 2019. "A View From Inside Cigna's $67 Billion Acquisition Of Express Scripts." Forbes. Angelica LaVito. Nov 28, 2018. "CVS creates new health-care giant as $69 billion merger with Aetna officially closes." CNBC. David Dayen. Oct 12, 2018. "Why the Aetna and CVS Merger Is So Dangerous." The American Prospect. Jeff Byers. April 12, 2018. "Optum a step ahead in vertical integration frenzy." Healthcare Dive. Graph: Optum opens up wider market for UnitedHealth Group Graph: Optum's pharmacy business contributes the majority of its revenue Susan Morse. May 10, 2017. "Secret weapon: UnitedHealth's Optum business is laying waste to old notions about how payers make money." Healthcare Finance. Lobbying "Client Profile: Pharmaceutical Care Management Assn." Open Secrets. The Demise of Independent Pharmacies Christine Blank. Oct 17, 2019. "Independents Prepare to Close Up Shop." Drug Topics. Paulina Firozi. Aug 23, 2018. "The Health 202: Here's why rural independent pharmacies are closing their doors." The Washington Post. What Is a Formulary? Ana Gascon Ivey. May 19, 2020. "A Guide to Medication Formularies." GoodRx. Previous Delays in Rebate Regulation Paige Minemyer. Jan 29, 2021. "In a win for PBMs, Biden administration delays rebate rule." Fierce Healthcare. Paige Minemyer. Jan 12, 2021. "PCMA sues Trump administration over rebate rule." Fierce Healthcare. "Incorporating the Effects of the Proposed Rule on Safe Harbors for Pharmaceutical Rebates in CBO's Budget Projections—Supplemental Material for Updated Budget Projections: 2019 to 2029." May 2019. Congressional Budget Office. The Gun Law Passage Process Office of the Clerk. May 18, 2022. "Roll Call 212 | Bill Number: S. 2938." U.S. House of Representatives. Tampa Bay Times Editorial Board. May 12, 2022. "Republican lawmakers should be ashamed for failing to honor Justice Joseph Hatchett." Miami Herald. Annie Karni. Apr 12, 2022. "House G.O.P., Banding Together, Kills Bid to Honor Pioneering Black Judge." The New York Times. Background on Most Important Provisions Mary Katherine Wildeman. May 26, 2022. "Data show most school shootings carried out by young adults, teens." CT Insider. Jeffrey Pierre. May 26, 2022. "Experts say we can prevent school shootings. Here's what the research says." NPR. The Dingleberry Erik Sherman. Jun 30, 2022. "Gun Safety Bill Extends Drug Middlemen Protection From Anti-Kickback Measure." Forbes. Molly Rutherford. Jun 28, 2022. "Gun legislation provision puts drug supply chain profits over patients." The Hill. Marty Schladen. Jun 22, 2022. "Deep inside the gun bill: a break for prescription drug middlemen." Iowa Capital Dispatch. Poland Train Station Taylor Popielarz, Maureen McManus and Justin Tasolides. Mar 25, 2022. "'The help given is remarkable': Inside the Poland train station that's become a hub for Ukrainian refugees." Spectrum News NY1. The Law and the Regulation S. 2938: Bipartisan Safer Communities Act Senate Vote: 65-33 (All Nos GOP) House Vote: 234-193 (All Nos GOP) Jen's Highlighted PDF of S. 2938: Bipartisan Safer Communities Act Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees U.S. Health and Human Services Department November 30, 2020 Audio Sources The State of Competition in the Pharmacy Benefits Manager and Pharmacy Marketplaces November 17, 2015 House Committee on the Judiciary Witnesses: Bradley J. Arthur, R.Ph., Owner, Black Rock Pharmacy David Balto, Law Offices of David A. Balto PLLC Amy Bricker, R.Ph. Vice President of Retail Contracting & Strategy, Express Scripts Natalie A. Pons, Senior Vice President and Assistant General Counsel, CVS Health Clips 53:48 Bradley Arthur: The Big Three PBMs control almost 80% of the entire market and these PBMs have the upper hand both in negotiating the contract with the payer, as well as strongly influencing the actual plan design itself. The PBM industry typically states that they can use their economic power to harness enhanced market efficiencies, but for whom? However, the staggering annual revenues that continue to grow each year of the big three suggests that these efficiencies are going directly to their corporations' bottom lines. Small community pharmacies like mine are faced on a daily basis with the impact of the PBMs' disproportionate market power. Community pharmacies routinely must agree to take-it-or-leave-it contracts from the PBMs just to continue to serve our long-standing patients. As if that weren't enough, the PBMs also directly set the reimbursement rates for pharmacies, the very same pharmacies that stand in direct competition of some of these PBM-owned mail-order and specialty pharmacies. Therefore, it comes as no surprise that the PBMs present employer and government payers with carefully tailored suggested plans designs that steer beneficiaries to these PBM-owned entities. Drug Pricing in America: A Prescription for Change, Part I January 29, 2019 Senate Committee on Finance Witnesses: Kathy Sego, Mother of a Child with Insulin-Dependent Diabetes Douglas Holtz-Eakin, Ph.D., President, American Action Forum Mark E. Miller, Ph.D., Vice President of Health Care, Laura and John Arnold Foundation Peter B. Bach, MD, MAPP, Director, Memorial Sloan Kettering Center for Health Policy and Outcomes Clips 1:57:30 Sen. John Cornyn (R - TX): Can anybody on the panel explain to me why we have a general prohibition against kickbacks — they call them rebates — under the Social Security Act, but we nevertheless allow it for prescription drug pricing? What's the sound public policy reason for excluding prescription drug pricing from the anti-kickback rule under federal law? Douglas Holtz-Eakin: I can't explain that and won't pretend to. [laughter] Sen. Cornyn: I thought I was the only one who didn't understand the wisdom of that. Well, it's not a transparent arrangement and it does produce upward pressure on drug prices. And obviously, the negotiations between the PBM and the pharma in terms of what the net cost is, is not transparent, nor is it delivered to the consumer. Is it Dr. Miller? Dr. Bach? Peter Bach: It's delivered to the consumer indirectly through the reduction of the total cost of the benefit, but it is not delivered to the actual consumer using the drug, and that is a disassociation, that is a problem. Because it essentially reverses the structure of insurance. Lowering the total costs are people who use it the least, and raising the costs are people who use it the most, relative to if you allowed the rebate to be used at the point of sale, including all discounts. 1:59:49 Douglas Holtz-Eakin: If we had the negotiation be about the upfront price, so instead of a high list price and a rebate, you just negotiate a lower price, that would be the price that Ms. Sego would pay and insurance companies would look at that and say, okay, she's not paying as much as she used to, we're going to have to make up that money somewhere else and they might raise premiums. That means that people who don't have extreme insulin drug costs would pay a little bit more in a premium every month, and people who have extremely devastating medical conditions and high health care costs would get less costs. That's exactly what insurance is supposed to do. And so the rebate system is more than giving strange incentives on pricing. It's undercutting the purpose of insurance in general. Drug Pricing in America: A Prescription for Change, Part II February 26, 2019 Senate Committee on Finance Witnesses: Richard A. Gonzalez, Chairman and Chief Executive Officer, AbbVie Inc. Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca Giovanni Caforio, M.D., Chairman of the Board and Chief Executive Officer, Bristol-Myers Squibb Co. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals, Johnson & Johnson Kenneth C. Frazier, Chairman and Chief Executive Officer, Merck & Co., Inc. Albert Bourla, DVM, Ph.D., Chief Executive Office, Pfizer Olivier Brandicourt, M.D., Former Chief Executive Officer, Sanofi Clips 1:22:03 Albert Bourla: Adverse incentives that favor higher cost biologics are keeping biosimilars from reaching patients. In many cases, insurance companies declined to include lower cost biosimilars in their formularies because they would risk losing the rebates from covering higher cost medicines. I can't think of a more concerning example of a broken system and we need to do something about it. 1:33:35 Sen. Chuck Grassley (R - IA): So many of you have voiced support for the recent rebate rule proposed by the administration. Should the administration finalized this rule, will you commit to lowering your drug prices? Richard Gonzalez [CEO, AbbVie]: Mr. Chairman, we are supportive of the rule. We'd like to see it in its final form, obviously, to make a final decision, but we are supportive of taking the discount to the patient at the point of sale. Sen Grassley: Okay. AstraZeneca? **Pascal Soriot [CEO, AstraZeneca]**The same for us Senator, I would go one step further: if the rebates were removed from the commercial sector as well, we will definitely reduce our list prices. Sen Grassley: Okay. And Bristol? Giovanni Caforio [CEO, Bristol-Myers Squibb]: We have the same positions. Sen Grassley: Okay. Johnson and Johnson? Jennifer Taubert [EVP, J&J]: Yes, we're supportive, and that definitely would be my goal. We would just need to see the final legislation, provided that there aren't additional fees that are added into the system to compensate for the rebates. Sen Grassley: Merck? **Kenneth C. Frazier: I would expect that our prices would go down if we change the system. Again, on the commercial side as well as the Medicare side. Sen Grassley: Okay, Pfizer? Albert Bourla [CEO, Pfizer]: It is a very clear intention that we will not keep a single dollar from these rebates. We will try to move every single penny to the patients and we think if this goes also to the commercial plants that will be even better for more patients. Sen Grassley: Okay. Sanofi? Olivier Brandicourt [Former CEO, Sanofi]: Lowering list price has to be linked to better access and affordability at the counter for the patients. 1:35:20 Sen. Ron Wyden (D - OR): Is it correct that your company, and nobody else, sets the starting price for all drugs sold by Pfizer? Yes or no? Albert Bourla: It is a negotiation with PBMs and they are very powerful. Sen. Wyden: But you still get to set the list price? Albert Bourla: Yes, but we set this price and the rebate limit(?). 1:35:40 Sen. Ron Wyden (D - OR): Is it correct, when a hypothetical patient, let's call her Mrs. Jones, goes to pay for her drug at the pharmacy counter, her coinsurance is based on the price of the drug you set? Albert Bourla: It is correct in many cases. Sen. Wyden: Okay. I just want you all to know that the number one reason consumers are getting hammered, is because these list prices, which you have the last word with respect to where they are, are unaffordable. And the high prices are tied to what the consumer pays at the pharmacy counter. And all this other stuff you talk about, the rebates and the discounts and the coupons, all this other stuff is window dressing, all of that. And the fact is on Part D, 40% of the drugs don't even have a rebate. So I want it understood, particularly because I've asked you, Mr. Borla, I think you and others in the industry are stonewalling on the key issue, which is actually lowering list prices. And reducing those list prices are the easiest way for American consumers to pay less at the pharmacy counter. 2:12:45 Sen. Thomas Carper (D-DE): First is eliminating rebates to PBMs. That's the first one, eliminating rebates to PBMs. The second is value based arrangements. And the third is increasing transparency industry-wide on how you set your prices. 2:13:20 Richard Gonzalez: We clearly support providing the discount at the patient level, eliminating rebates essentially. 2:14:10 Pascal Soriot: If the rebates, as I said earlier, were to be removed from Part D and the commercial sector, we would actually reduce our list prices. 2:15:10 Giovanni Caforio: I would say that not only do we support all three elements that you mentioned, but I do believe those three elements together with the continued effort to develop a gen…

    Full show notes at the publisher

    CD254: Baby Formula Shortage Jun 26, 2022
    Show notes

    After multiple formula-related infant deaths were reported to the FDA in February, samples from Abbott Laboratories' Sturgis, Michigan baby formula production facility tested positive for cronobacter, triggering a recall and a subsequent formula shortage. In this episode, Jen uncovers monopoly and neglect in the baby formula production industry, lack of oversight by the FDA, and the United States' refusal to adopt the World Health Organization's International Code of Marketing of Breast-Milk Substitutes. Please Support Congressional Dish – Quick Links Contribute monthly or a lump sum via PayPal Support Congressional Dish via Patreon (donations per episode) Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: 5753 Hwy 85 North, Number 4576, Crestview, FL 32536. Please make checks payable to Congressional Dish Thank you for supporting truly independent media! View the shownotes on our website at https://congressionaldish.com/cd254-baby-formula-shortage Background Sources Recommended Congressional Dish Episodes CD234: AWOL Recall: The Rock and Play Sleeper The Formula Shortage Abbott. Jun 15, 2022. "Update on Abbott's Sturgis Plant and Formula Production." "Testimony of Robert M. Califf, M.D., Commissioner of Food and Drugs, Food and Drug Administration, Department of Health and Human Services, before the Committee on Health, Education, Labor & Pensions, Infant Formula Crisis: Addressing the Shortages and Getting Formula on Shelves." May 26, 2022. U.S. Senate. Center for Food Safety and Applied Nutrition. May 18, 2022. "Guidance for Industry: Infant Formula Enforcement Discretion Policy" [FDA–2022–D–0814]. U.S. Food and Drug Administration. Annie Gasparro and Jaewon Kang. May 12, 2022. "Baby Formula Shortage Could Leave Parents Scrambling for Months." The Wall Street Journal. U.S. Food and Drug Administration. Feb 2022. "FDA Investigation of Cronobacter Infections: Powdered Infant Formula." Baby Formula Monopoly Matt Stoller. May 13, 2022. "Big Bottle: The Baby Formula Nightmare." BIG by Matt Stoler on Substack. Sam Knight. Apr 23, 2022. "Company Responsible for Tainted Baby Formula Has Monopoly Over Aid Program Sales." Truthout. FDA Failure Letter from Rep. Raja Krishnamoorthi to FDA Commissioner Robert Califf. March 24, 2022. U.S. House of Representatives. Poisoned Baby Food House Committee on Oversight and Reform, Subcommittee on Economic and Consumer Policy Staff. Feb 4, 2021. "Report: Baby Foods Are Tainted with Dangerous Levels of Arsenic, Lead, Cadmium, and Mercury." Operation Fly Formula Brenda Goodman and Deidre McPhillips. Jun 10, 2022. "How far will Operation Fly Formula shipments really go to fill America's store shelves?" CNN. The White House. May 22, 2022. "Biden Administration Announces Second Operation Fly Formula Flight." White House Briefing Room: Statements and Releases. 60 minutes Segment Bill Whitaker. May 22, 2022. "Medical Middlemen: Broken system making it harder for hospitals and patients to get some life-saving drugs." 60 Minutes. The WHO Code and Formula Marketing The World Health Organization. Apr 28, 2022. "Scope and impact of digital marketing strategies for promoting breastmilk substitutes." The World Health Organization. Apr 28, 2022. "WHO reveals shocking extent of exploitative formula milk marketing." The World Health Organization. #EndExploitativeMarketing Petition. La Leche League International. "International WHO Code." Bonnie Goldstein. Jul 13, 2018. Paper Cuts: No Match for Mother's Milk. Project on Government Oversight. Baby-Friendly USA website. The World Health Organization. Jan 27, 1981. "International Code of Marketing of Breast-Milk Substitutes." Fisher-Price Update Katie Porter [@RepKatiePorter]. Jun 15, 2022. "Following yesterday's news of previously unreported infant deaths in Fisher-Price products, I'm calling on the company to immediately recall all…" Twitter. Laws H.R.7791: Access to Baby Formula Act of 2022 Jen's Highlighted PDF of Public Law 117–129 H.R.3182: Safe Sleep for Babies Act of 2021 Audio Sources INFANT FORMULA CRISIS May 26, 2022 Senate Committee on Health, Education, Labor, and Pensions The committee concluded a hearing to examine the infant formula crisis, focusing on addressing the shortage and getting formula on shelves. Witnesses: Robert M. Califf, Commissioner of Food and Drugs, Food and Drug Administration Clips 37:26 Dr. Robert Califf: Frankly, the inspection results were shocking. Standing water, cracks in key equipment that presented the potential for bacterial contamination to persist, particularly in the presence of moisture, leaks in the roof, a previous citation of inadequate hand washing and current poor foot sanitation, bacteria growing from multiple sides, and many signs of a disappointing lack of attention to the culture of safety in this product that is so essential to the lives of our most precious people. 38:14 Dr. Robert Califf: As soon as we receive positive cronobacter results from environmental samples at the facility that we collected during the inspection, we contacted Abbott to ask the company to issue a voluntary recall. The need to take urgent action to protect the most vulnerable of all of our people -- infants -- presented a dilemma. This was the largest plant of the dominant manufacturer, and it was the sole source of a number of metabolic formulas essential for viability of infants with no substitution possible, because Abbott had no backup plan. We knew that ceasing plant operations would create supply problems, but we had no choice given the unsanitary conditions. 50:50 Sen. Richard Burr (R-NC): Why haven't you waived labeling requirements from trusted manufacturers in countries like the UK, Australia or Canada? Couldn't manufacturers provide temporary labels on imported formula? Cans if the label is printed in a language other than English until US manufacturing is restored? Some countries have higher nutritional requirements. Why can't we provide a waiver for their products to come into the country? Dr. Robert Califf: We've waived many of the requirements that are the ones that make sense, but the directions have to be clear to Americans in language that's understandable so the formula can be mixed correctly. An error in mixing up the formula for example, can lead to a very sick infant not getting the right nutrition. 2:16:18 Dr. Robert Califf: We saw the lack of quality in the system and the lack of accountability for the problems that were there. And so we had to invoke the Justice Department to negotiate a consent decree, which is essentially Abbott saying, "Yes, we had all these problems. Here's exactly what we're going to do to fix them." For legal reasons, I can't discuss the exact details of the negotiation, but let's just say that it took a little armwrestling to get to the point where the Justice Department got Abbott to sign the consent decree. FORMULA SAFETY AND SUPPLY: PROTECTING THE HEALTH OF AMERICA'S BABIES May 25, 2022 Committee on Energy and Commerce: Subcommittee on Oversight and Investigations Witnesses: Robert M. Califf, Commissioner, Food and Drug Administration Frank Yiannas, Deputy Commissioner, Food Policy and Response, Food and Drug Administration Susan Mayne, Director, Center for Food Safety and Applied Nutrition, Food and Drug Administration Chris Calamari, Senior Vice President of U.S. Nutrition, Abbott Robert Cleveland, Senior Vice President of the Nutrition Business Unit for the US and Europe, Mead Johnson Nutrition Scott Fitz, Vice President of Technical and Production, Gerber Clips 41:55 Robert Califf: Because of the lack of the diversification of this market in the absence of a central hub for integrating supply chains, we concluded early on that getting the Sturgis facility up and running safely was a top priority. But we had no confidence in the integrity of the Abbott quality program at this facility. Accordingly, we initiated proceedings toward a consent decree, which requires Abbott to undertake steps to assure safe production of formula, including hiring an outside expert with reporting to FDA. 43:03 Robert Califf: Despite the overall numbers showing diminished but steady supply, we knew that distribution was an issue. Some areas were experiencing significant shortages, but overall, there was enough formula to go around. About a month ago, the reports of shortages on the shelf proliferated, although there was not a drop in production. This increase in consumption most likely represents heightened concern of parents and caregivers about shortages, leading to an understandable effort to purchase ahead to ensure adequate supply at home. This type of cycle has happened with other products throughout the pandemic, and we realize that the only solution is to have adequate supply to make sure shelves are stocked. 45:57 Robert Califf: Abbott's enormous market share left it with a responsibility for producing safe infant formula that was not met. We will do everything in our power to work with Abbott to make this happen as quickly and as safely possible, but this timing is an Abbott's control. 46:35 Robert Califf: Across the industry we regulate, we are seeing evidence that the just-in-time distribution system, market concentration, and sole-source contracting are leading to shortages. Multiple reports to Congress call for improved supply chain management. Until regulatory agencies have digital access to critical supply chain information and personnel to do the work, we will continue to react to supply chain disruptions rather than intervening to prevent them. 1:01:113 Robert Califf: It's really important for people to go to the HHS website: hhs.gov/formula. There you'll find the hotline for all the manufacturers and helpful information about where to go. 1:04:12 Robert Califf: You would be surprised to know there's no just-in-time system where all the FDA employees can see what's going on. What we really need is access to the information that the manufacturers have about each of their individual supply chains. They each have their individual supply chains, but there is no national system to make sure the supplies getting where it needs to go. 1:05:11 Rep. Cathy McMorris Rodgers (R-WA): Did FDA not have a data analytics tool to monitor the supply chains of various products, including infant formula? Robert Califf: We requested funding for a tool and because we didn't get the funding, we cobbled it together. It's a start, but it's nowhere near — you know, again, I was at Google for five years. The technology at FDA, and in many federal agencies is outmoded and needs an upfit, there's just no question about. 1:07:33 Susan Mayne: We have been in discussion with infant formula manufacturers throughout COVID, but discussion is not the same thing as data and we do not have the authorities to demand data from the companies to get necessarily all the information that you would want to have to really monitor the supply chains as Dr. Califf indicated. 1:10:30 Robert Califf: But given what we saw, the only way we could have confidence was through a consent decree, where we literally have oversight of every single step. When we met with the CEO yesterday, there were hundreds of steps that they went through that they're having to do, many of which have already been done. So it's only if we have direct oversight over it that I would have confidence, but I do have confidence that we are seeing every single step both physically in-person, and also through following the documentation and the outside expert. 1:10:53 Rep. David B. McKinley (R-WV): How will the passage of last week's FDA Bill increase the production of baby formula? Robert Califf: Production is increasing already — Rep. David McKinley The criticism, that they said that on these various tweets — it was not just one there were several — that said it was unnecessary. So I want to know, how do we increase, how do we get back to production? How to put in $28 million? How would that how's that gonna increase production? Robert Califf: Well, remember, the Abbot plant needs to get up and running, we've got to oversee and micro detail to make sure that it's done correctly. And as we bring in supply from other countries, remember, we already have overseas plants that we import from on a regular basis, almost double digits. So as we bring that product in, we've got to inspect it, make sure it's of the quality that we expect in America of formula and we need to upgrade our information systems, as I've already said, to make sure that as all this goes on, we can keep track of it and make sure that we're coordinated. 1:44:55 Rep. Kim Schrier (D-WA): Is there any early warning system for products like baby formula? And not just the ingredients but for formula itself or manufacturer would let you know if they're running short or anticipate a shortage? Robert Califf: First of all, let me thank you for being a pediatrician. I sometimes call the Academy of Pediatrics just for the positive vibes that you all exude as a profession. But no, there is not such a warning system. We've repeatedly asked for that authority and have not been granted it. The industry by and large has opposed it. 1:52:21 Susan Mayne: What the data show is, we can't rule in or rule out whether or not those infants, their cronobacter was caused by this plant. The data just simply can't be used to inform it. Rep. John Joyce (R-PA): But the genetic testing you did. It does not match from the plant, correct? Susan Mayne: That is correct. But what we did not have is any sampling done at the same time that the product was manufactured that was consumed by the individuals who got sick, so we didn't have that every director 2:08:57 Rep. Ann Kuster (D-NH): I know that in this part of the country, I'm in New Hampshire, we have milk banks of mother's breast milk. And I'm wondering what is the regulation by the FDA? And can we assure our constituents that breast milk from milk bank is safe and is thoroughly vetted by the FDA? Robert Califf: You're asking some very good questions. I'm gonna refer this to Dr. Mayne who probably would have the best answer. Susan Mayne: Thank you, Congresswoman. So human breast milk is regulated as a food. And so that is reassuring and they have to have proper screening protocols and things like that in place to make sure that the donors that are donating the milk, get that, that's critical for human food safety. So that's how I would respond. Thank you. 2:26:28 Robert Califf: You would think that a critical industry like this would have resilience plans, redundancy, but we don't even have legal authority right now to require that the firms have a plan for potential failures and resilience. That's something we've asked Congress for every year for a while, and we're asking for it again. So I hope that it happens this time. I'd also add that this is not unique to this industry. We are seeing this across the entire device and medical supply industry with frequent failures as exemplified by the 60 minutes show and the contrast medium problem that I talked about. We have gone to a just-in-time, large single source contracts that lead to lack of diversification in the industry and the industry has fought us tooth and nail on requiring that there be insight into their supply chains, so that the sum of all of the industr…

    Full show notes at the publisher

    CD253: Escalation of War Jun 06, 2022
    Show notes

    Since the Russian invasion of Ukraine began, Congress has signed four laws that send enormous amounts of money and weapons to Ukraine, attempting to punish Russia for President Putin's invasion. In this episode, we examine these laws to find out where our money will actually go and attempt to understand the shifting goals of the Biden administration. The big picture, as it's being explained to Congress, differs from what we're being sold. Please Support Congressional Dish – Quick Links Contribute monthly or a lump sum via PayPal Support Congressional Dish via Patreon (donations per episode) Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: 5753 Hwy 85 North, Number 4576, Crestview, FL 32536. Please make checks payable to Congressional Dish Thank you for supporting truly independent media! Background Sources Recommended Congressional Dish Content Ukraine and Russia CD249: A Few Good Laws CD248: Understanding the Enemy CD244: Keeping Ukraine CD229: Target Belarus CD167: Combating Russia (NDAA 2018) LIVE CD068: Ukraine Aid Bill CD067: What Do We Want In Ukraine? Syria CD172: The Illegal Bombing of Syria CD108: Regime Change CD041: Why Attack Syria? World Trade System What Is the World Trade System? CD230: Pacific Deterrence Initiative CD102: The World Trade Organization: COOL? Russian Blockade Shane Harris. May 24, 2022. "U.S. intelligence document shows Russian naval blockade of Ukraine." The Washington Post. NATO Expansion Jim Garamone. Jun 1, 2022. "Russia Forcing Changes to NATO Strategic Concepts." U.S. Department of Defense News. Matthew Lee. May 27, 2022. "US: Turkey's NATO issues with Sweden, Finland will be fixed." AP News. Ted Kemp. May 19, 2022. "Two maps show NATO's growth — and Russia's isolation — since 1990." CNBC. U.S. Involvement in Ukraine Helene Cooper, Eric Schmitt and Julian E. Barnes. May 5, 2022. "U.S. Intelligence Helped Ukraine Strike Russian Flagship, Officials Say." The New York Times. Julian E. Barnes, Helene Cooper and Eric Schmitt. May 4, 2022. "U.S. Intelligence Is Helping Ukraine Kill Russian Generals, Officials Say." The New York Times. Private Security Contractors Christopher Caldwell. May 31, 2022. "The War in Ukraine May Be Impossible to Stop. And the U.S. Deserves Much of the Blame." The New York Times. Joaquin Sapien and Joshua Kaplan. May 27, 2022. "How the U.S. Has Struggled to Stop the Growth of a Shadowy Russian Private Army." ProPublica. H.R. 7691 Background How It Passed Glenn Greenwald. May 13, 2022. "The Bizarre, Unanimous Dem Support for the $40b War Package to Raytheon and CIA: 'For Ukraine.'" Glenn Greenwald on Substack. Catie Edmondson and Emily Cochrane. May 10, 2022. "House Passes $40 Billion More in Ukraine Aid, With Few Questions Asked." The New York Times. Republican Holdouts Glenn Greenwald and Anthony Tobin. May 24, 2022. "Twenty-Two House Republicans Demand Accountability on Biden's $40b War Spending." Glenn Greenwald on Substack. Amy Cheng and Eugene Scott. May 13, 2022. "Rand Paul, lone Senate holdout, delays vote on Ukraine aid to next week." The Washington Post. Morgan Watkins. May 13, 2022. "Sen. Rand Paul stalls $40 billion in aid for Ukraine, breaking with Mitch McConnell USA Today. Stephen Semler. May 26, 2022. "The Ukraine Aid Bill Is a Massive Windfall for US Military Contractors." Jacobin. Biden Signs in South Korea Biden signs Ukraine Bill and Access to Baby Formula Act in South Korea. Reddit. Kate Sullivan. May 20, 2022. "Flying the Ukraine aid bill to South Korea for Biden's signature isn't unheard of. It also may not be totally necessary." CNN. How Much Money, and Where Will It Go? Stephen Semler. May 23, 2022. "A breakdown of the Ukraine aid bill." Speaking Security on Substack. "CBO Estimate for H.R. 7691, Additional Ukraine Supplemental Appropriations Act, 2022, as Passed by the House of Representatives on May 10, 2022." May 11 2022. Congressional Budget Office. Christina Arabia, Andrew Bowen, and Cory Welt. Updated Apr 29, 2022. "U.S. Security Assistance to Ukraine." [IF12040] Congressional Research Service. "22 U.S. Code § 2346 - Authority." Legal Information Institute, Cornell School of Law. Representatives' Raytheon and Lockheed Martin Stocks Kimberly Leonard. May 19, 2022. "20 members of Congress personally invest in top weapons contractors that'll profit from the just-passed $40 billion Ukraine aid package." Insider. Kimberly Leonard. Mar 21, 2022. "GOP Rep. John Rutherford of Florida bought Raytheon stock the same day Russia invaded Ukraine." Insider. Marjorie Taylor Green [@RepMTG]. Feb 24, 2022. "War is big business to our leaders." Twitter. "Florida's 4th Congressional District." GovTrack. "Rules Based Order" Anthony Dworkin. Sep 8, 2020. "Why America is facing off against the International Criminal Court." "History of the multilateral trading system." *The World Trade Organization "Facts: Global Inequality" Inequality.org "Timeline: Former Russian President Boris Yeltsin." Apr 23, 2007. NPR. Crimea Kenneth Rapoza. Mar 20, 2015. One Year After Russia Annexed Crimea, Locals Prefer Moscow To Kiev Forbes. "Crimea exit poll: About 93% back Russia union. March 16, 2014. BBC. Shifting Strategies Economic War Larry Elliott. Jun 2, 2022. "Russia is winning the economic war - and Putin is no closer to withdrawing troops. The Guardian. Nigel Gould-Davies. May 12, 2022. "We Must Make Sure Russia Finishes This War in a Worse Position Than Before" The New York Times. Weapons Escalation Jake Johnson. Jun 1, 2022. "'Slippery Slope... Just Got a Lot Steeper': US to Send Ukraine Advanced Missiles as Russia Holds Nuke Drills." Common Dreams. C. Todd Lopez. Jun 1, 2022. "Advanced Rocket Launcher System Heads to Ukraine." U.S. Department of Defense News. Greg Norman. Jun 1, 2022. "Russia stages nuclear drills after US announces rockets to Ukraine." Fox News. Christian Esch et al. May 30, 2022. "What's Next for Ukraine? The West Tries to Figure Out What Peace Might Look Like." Spiegel International. See Image. Alastair Gale. May 24, 2022. "China and Russia Sent Bombers Near Japan as Biden Visited Tokyo." The Wall Street Journal. Mike Stone. Mar 11, 2022. "Exclusive: Pentagon revives team to speed arms to Ukraine and allies, sources say." Reuters. Secretary Austin and the Pentagon Jim Garamone. May 20, 2022. "Austin to Host Second Ukraine Contact Group Meeting Monday." U.S. Department of Defense News. Natasha Bertrand et al. Apr 26, 2022. "Austin's assertion that US wants to 'weaken' Russia underlines Biden strategy shift." CNN. David Sanger. Apr 25, 2022. "Behind Austin's Call for a 'Weakened' Russia, Hints of a Shift." The New York Times. Mike Stone. Apr 12, 2022. "Pentagon asks top 8 U.S. weapons makers to meet on Ukraine -sources." Reuters. Glenn Greenwald. Dec 8, 2020. "Biden's Choice For Pentagon Chief Further Erodes a Key U.S. Norm: Civilian Control." Glenn Greenwald on Substack. Democrats Still All In Marc Santora. May 1, 2022. "Pelosi and Democratic lawmakers vow the U.S. will stand with Ukraine. The New York Times. RFE/RL's Ukrainian Service. May 1, 2022. "Civilians Evacuated From Mariupol; U.S. House Speaker Pelosi Visits Kyiv." Radio Free Europe/Radio Liberty. "Ukraine war: Joe Biden calls for removal of Vladimir Putin in angry speech." Mar 26, 2022. Sky News. The Laws H.R. 7691: Additional Ukraine Supplemental Appropriations Act, 2022 House Vote: 368-57 Senate Vote: 86-11 Transcript of House Debate S.3522: Ukraine Democracy Defense Lend-Lease Act of 2022 Passed by Voice Vote in the Senate House Vote 417-10 House "Debate" H.R.6968 - Ending Importation of Russian Oil Act Senate Vote: 100-0 House Vote: 413-9 House Debate H.R.7108: Suspending Normal Trade Relations with Russia and Belarus Act Senate Vote: 100-0 (amended the original House bill) Final House Vote: 424-8 House debate 1 (on original version) House debate 2 (final version) Audio Sources Joe Manchin at the World Economic Forum's meeting in Davos May 23, 2022 Clips Sen. Joe Manchin (D-WV): Speaking about Ukraine, first what Putin, Putin's war on Ukraine and Ukraine's determination, resolving the sacrifices they've made for the cause of freedom has united the whole world, that it's united, US Senate and Congress, I think like nothing I've seen in my lifetime. I think we're totally committed to supporting Ukraine, in every way possible, as long as we have the rest of NATO and the free world helping. I think we're all in this together. And I am totally committed as one person to seeing Ukraine to the end with a win, not basically resolving in some type of a treaty. I don't think that is where we are and where we should be. Reporter: Can I just follow up and ask you what you mean by a win for Ukraine? ** Sen. Joe Manchin:** I mean, basically moving Putin back to Russia and hopefully getting rid of Putin. The Ukraine Crisis: Implications for U.S. Policy in the Indo-Pacific May 19, 2022 Committee on Foreign Affairs, Subcommittee on Asia, the Pacific, Central Asia, and Nonproliferation Witnesses: Charles Edel, Ph.D., Australia Chair and Senior Adviser, Center for Strategic and International Studies Bonny Lin, Ph.D., Director, China Power Project, Center for Strategic and International Studies Tanvi Madan, Ph.D.Director, The India Project, Brookings Institution Dan Blumenthal, Ph.D., Senior Fellow and Director of Asian Studies, American Enterprise Institute Clips 6:57 Tanvi Madan: One implication that is already evident, most visibly in Sri Lanka, is the adverse economic impact. The rise in commodity prices in particular has led to fiscal food and energy security concerns and these, in turn, could have political implications and could create a strategic vacuum. 7:15 Tanvi Madan: A separate and longer term economic impact of the crisis could be renewed goals, perhaps especially in India, for self reliance and building resilience not just against Chinese pressure, but also against Western sanctions. 7:28 Tanvi Madan: The second potential implication of the Russia-Ukraine war could be that Beijing might seek to take advantage in the Indo-Pacific while the world's focus is on Europe, between the Taiwan or the East or South China Sea contingencies. The contingency that would have the most direct impact in South Asia would be further action by the PLA at the China-India boundary, or at the Bhutan-China boundary that could draw in India. This potential for Sino-Indian crisis escalation has indeed shaped Delhi's response to the Russia-Ukraine war. Despite its recent diversification efforts, the Indian military continues to be dependent, if not over dependent, on Russia for supplies and spare parts for crucial frontline equipment. India has also been concerned about moving Moscow away from neutrality towards taking China's side. Nonetheless, there is simultaneously concern that Russia's war with Ukraine might, in any case, make Moscow more beholden to Beijing and also less able to supply India, and that will have implications for India's military readiness. 10:10 Tanvi Madan: The fourth implication in South Asia could flow from the war's effect on the Russia-China relationship flows. The Sino-Russian ties in recent years have benefited Pakistan. However, they have been of great concern to India. If China-Russia relations deepened further, it could lead to increased Indian concern about Russian reliability. And a Dheli that is concerned about Moscow's ability and willingness to supply India militarily or supported in international forums will seek alternative partners and suppliers a potential opportunity for the US as well as its allies and partners. 18:15 Bonny Lin: China has shifted its position on the Ukraine conflict to be less fully pro Russia. Xi Jinping has expressed that he is deeply grieved by the outbreak of war. China has engaged in diplomacy, called for a ceasefire, proposed a six point humanitarian initiative, and provided humanitarian aid to Ukraine. China's position on Ukraine, however, is far from neutral. China has not condemned Russia or called its aggression an evasion. Xi has yet to speak to President Zelenskyy. There is no evidence that China has sought to pressure Russia in any way or form. China has amplified Russian disinformation and pushed back against Western sanctions. To date, Beijing has not provided direct military support to Russia and has not engaged in systemic efforts to help Russia evade sanctions. However, China's ambassador to Russia has encouraged Chinese companies to quote "fill the void in the Russian market." 19:14 Bonny Lin: The Ukraine crisis has reinforced China's view that US military expansion could provoke conflict in the Indo-Pacific. Chinese interlocutors have voiced concern that the United States and NATO are fighting Russia today, but might fight China next. China views NATO expansion as one of the key causes of the Korean conflict and sees parallels between NATO activities in Europe and US efforts in the Indo-Pacific. Beijing is worried that increasing US and ally support for Taiwan and other regional allies and partners elevates the risk of US-China military confrontation. This pessimistic assessment is why Beijing will continue to stand by Russia as a close strategic partner. 19:56 Bonny Lin: The Ukraine crisis has reinforced and strengthened China's desire to be more self reliant. China is investing more to ensure the security of food, energy, and raw materials. Beijing is also seeking more resilient industrial supply chains, as well as PRC-led systems, including alternatives to Swift. At the same time, Beijing is likely to further cultivate dependencies on China, such that any potential Western led sanctions on China or international-community-led sanctions on China in the future will be painful to the West and difficult to sustain. 21:15 Bonny Lin: China has observed that Russia put its nuclear and strategic forces on high alert and NATO did not send conventional forces to Ukraine. This is leading China to question its nuclear policy and posture. 21:57 Bonny Lin: As Beijing watches the Western and particularly G7-led unity among advanced democracies, it is also seeing that a number of countries in the developing world are not joining in on the sanctions. As a result, Beijing has tried to increase its influence and in many ways building on Russian influence in developing regions. And Beijing is likely to try to get all that influence moving forward. 24:24 Dan Blumenthal: China took the opportunity of Russia's invasion on February 4 to lay out a document that criticizes, very specifically, almost all aspects of United States global policy. Very specifically, including Oculus for NATO enlargement to Oculus to the Indo Pacific strategy. It got Russia to sign up to Xi Jinping's theory that we're in a new era of geopolitics that will replace US leadership, that US leadership is faulty and it's dividing the world into blocks such as NATO, that NATO expansion is the problem, that Indo-Pacific strategy is the same thing as NATO expansion. 25:45 Dan Blumenthal: We should take very seriously what they say, particularly in Chinese, and what they're sayin…

    Full show notes at the publisher

    CD252: Women's Health Protection Act May 22, 2022
    Show notes

    The Women's Health Protection Act is a bill written by Democrats that would guarantee access to abortion services in the United States. While this bill is unlikely to become law, learning what exactly the Democrats are proposing is instructive, as many of us will be voting with abortion in mind later this year. Now that the Supreme Court is poised to overturn previous decisions that guaranteed access to abortion services for the past 50 years, what do Democrats hope to do in response? Please Support Congressional Dish – Quick Links Contribute monthly or a lump sum via PayPal Support Congressional Dish via Patreon (donations per episode) Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: 5753 Hwy 85 North, Number 4576, Crestview, FL 32536. Please make checks payable to Congressional Dish Thank you for supporting truly independent media! View the show notes on our website at https://congressionaldish.com/cd252-womens-health-protection-act/ Links to We're Not Wrong We're Not Wrong on Apple Podcasts We're Not Wrong on Podcast Addict Executive Producer Recommended Episode CD190: A Coup for Capitalism Follow up reading: Tom Phillips, Patrick Wintour and Julian Borger. May 19, 2022. "Maduro glimpses political lifeline as US rethinks Venezuela policy." The Guardian. Background Sources Recommended Congressional Dish Episode CD032: The Abortion Bill Abortion Background Laura Temme. May 12, 2022. "Roe v. Wade Case Summary: What You Need to Know" FindLaw. Grace Panetta, Shayanne Gal, and Taylor Tyson. Updated May 9, 2022. "The latest point in pregnancy you can get an abortion in all 50 states." Business Insider. Jon O. Shimabukuro. Feb 25, 2022. "Abortion: Judicial History and Legislative Response." [RL33467] Congressional Research Service. Katherine Kortsmit et. al. Nov 27, 2020. "Abortion Surveillance — United States, 2018." Centers for Disease Control and Prevention. United Kingdom National Health Service. "Week-by-week guide to pregnancy" Start for Life. A. Pawlowski. Nov 9, 2017. "'Miracle baby': Born at 21 weeks, she may be the most premature surviving infant." Today. Supreme Court of the United States. Jun 29, 1992. "Planned Parenthood of Southeastern Pa. v. Casey, 505 U.S. 833." Justia. The Draft Decision Adeel Hassan. May 6, 2022. "What to Know About the Mississippi Abortion Law Challenging Roe v. Wade." The New York Times. Supreme Court of the United States. Feb 10, 2022. "1st Draft: Dobbs v. Jackson Women's Health Organization" Bills H.R.3755 (117th): Women's Health Protection Act of 2021 Sponsor: Rep. Judy Chu (D-CA) Text of House Bill House Vote Breakdown S.4132 (177th): Women's Health Protection Act of 2022 Sponsor: Sen. Richard Blumenthal (D-CT) Text of Senate Bill Senate Cloture Vote Breakdown Bill Outline Section 3: Permitted Services Gives health care providers the right to provide abortion services and gives patients the right to receive abortion services "without any of the following limitations or requirements": Requirements to perform specific tests or medical procedures prior to an abortion Requirements that direct health providers to provide medically inaccurate information before or during abortion services Limitations on the health care provider's ability to provide drugs to the patient Limitations preventing the health care provider from performing abortion services via telemedicine Limitations placed on abortion providing facilities that are not placed on hospitals and other facilities where similar procedures are performed Requirements that the patient attend medically unnecessary pre-abortion in-person office visits Limitations on abortions "at any point or points in time prior to fetal viability" Limitations on abortions "after fetal viability when, in the good-faith medical judgement of the treating health care provider, continuation of the pregnancy would pose a risk to the pregnant patient's life or health." Requirements that patients disclose the reason they want an abortion prior to fetal viability. Allows the courts to consider the following in determining if a requirement illegally impedes access to abortion services: If the requirement interferes with a health care providers ability to provide care and services or poses a risk to the patient's health or safety If the requirement would likely delay or deter some patients from accessing abortion services If the requirement is likely to increase the financial costs of providing or obtaining abortion services If the requirement would likely limit the availability of abortion services in a State or geographic region If the requirement imposes penalties on health care providers that are not imposed on or are more severe than penalties imposed on other health care providers for comparable conduct or failures to act Section 4: Applicability and Preemption This law would apply to the Federal Government and "each State government" and no State government can implement and enforce any law or regulation that conflicts with this law. The law would not govern physical access to clinic entrances, insurance coverage for abortions, contracts, or bans on partial birth abortions. Section 5: Effective Date Immediately upon enactment. Section 7: Enforcement Allows the Attorney General to sue any State or government official who implements or enforcement limitations or requirements that would be prohibited by this law. Allows individuals, "entities", and health care providers adversely affected by violations of the law to also sue the State that violates the law with illegal limitations and requirements The costs of the trial and attorney's fees would be paid by the State if the State loses the case. The person suing could not be forced to pay for attorney's fees if the claim was judged to be "non-frivolous" even if they lose. H.R. 1797 (113th): Pain-Capable Unborn Child Protection Act Sponsor: Trent Franks (R-AZ) Status: Died in 113th Congress Audio Sources Senate Session May 10, 2022 View Clip Transcripts in Jen's Highlighted PDF House Session September 24, 2021 View Clip Transcripts in Jen's Highlighted PDF Cover Art Design by Only Child Imaginations Music Presented in This Episode Tired of Being Lied To by David Ippolito


    Previous 1 8 9 10 11 12 36 Next

    Related Podcasts

    Inside Strategic Coach: Connecting Entrepreneurs With What Really Matters

    1

    Inside Strategic Coach: Connecting Entrepreneurs With What Really Matters Business
    WSJ Your Money Briefing

    2

    WSJ Your Money Briefing Business
    FORTUNE Unfiltered with Aaron Task

    3

    FORTUNE Unfiltered with Aaron Task Business
    FORTUNE OnStage Presents: The Most Powerful Women

    4

    FORTUNE OnStage Presents: The Most Powerful Women Business
    Slate Money

    5

    Slate Money Business
    In The Dark – The New Yorker

    6

    In The Dark – The New Yorker Business News
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights